{"text": "CT perfusion is a feasible , reproducible technique for assessing tissue perfusion in locally advanced HCC [ 14 ] .Measures of tumor perfusion have been correlated with angiogenesis and microvessel density within the tumor [ 14 , 15 ] .", "label": "", "metadata": {}, "score": "19.006557"}
{"text": "CT perfusion scan for patients with HCC allows assessment of perfusion changes due to transarterial chemoembolization ( TACE ) .There are few reports on the application of this technique in evaluating the efficacy of TACE based on the quantitative analysis of perfusion parameters .", "label": "", "metadata": {}, "score": "22.792835"}
{"text": "This study reported the changes of CT perfusion parameters in different treatment response groups and provides a useful imaging modality for monitoring treatment response to HCC .", "label": "", "metadata": {}, "score": "25.331089"}
{"text": "CT perfusion allows quantitative analysis of tumor BF and blood volume ( BV ) of HCC in clinical assessment .Perfusion CT , as a quantitative biomarker of angiogenesis , has been applied in studies of lung , colorectal , renal , and liver cancers [ 9 - 12 ] .", "label": "", "metadata": {}, "score": "26.112406"}
{"text": "Post - treatment changes in perfusion parameters are correlated with different therapeutic efficacies for HCC .Thus , CT perfusion imaging is a feasible and non - invasive technique for monitoring treatment response to TACE .", "label": "", "metadata": {}, "score": "31.859596"}
{"text": "All patients underwent CT perfusion examinations pre-(1 d before TACE ) and post - treatment ( 4 wk after TACE ) .CT perfusion imaging technique .", "label": "", "metadata": {}, "score": "32.65863"}
{"text": "In this study , changes in parameters of CT perfusion pre- and post - TACEwere observed in different treatment response groups .Applications .CT perfusion imaging , a feasible and non - invasive technique , can be used for monitoring treatment response to TACE .", "label": "", "metadata": {}, "score": "33.433167"}
{"text": "Background .Computed tomography ( CT ) perfusion imaging is a non - invasive and non - invasive technique for assessing tissue perfusion in locally advanced HCC .", "label": "", "metadata": {}, "score": "33.628365"}
{"text": "The second difference in this study is that we used CT perfusion imaging by combining dedicated software with dual - vessel input of CT perfusion .", "label": "", "metadata": {}, "score": "34.26599"}
{"text": "Response Evaluation Criteria in Solid Tumors .SPECT : . single - photon emission computed tomography .TACE : . transarterial chemoembolization .TTP : . time to progression .", "label": "", "metadata": {}, "score": "34.862133"}
{"text": "CT Perfusion Parameters and Microvessel Density ( MVD ) .The average size of the target HCCs in 21 patients was 8.2 cm .The results of the CT perfusion parameters between HCCs and their surrounding liver parenchyma were shown in Table 1 .", "label": "", "metadata": {}, "score": "34.87933"}
{"text": "The introduction of multi - detector CT has stimulated further interest in perfusion CT techniques and their future implementation in clinical practice [ 14 ] .", "label": "", "metadata": {}, "score": "35.266766"}
{"text": "Therefore , in the CR group , the perfusion parameters of post - treatment tumor could not be generated .In the SD treatment response group , no significant difference was found in all CT perfusion parameters pre- and post - TACE ( Table 1 ) .", "label": "", "metadata": {}, "score": "35.924477"}
{"text": "The response evaluation criteria for solid tumors ( RECIST ) were referred to when treatment responses were distributed .Wilcoxon - signed ranks test was used to compare the differences in CT perfusion parameters pre- and post - TACE for different response groups .", "label": "", "metadata": {}, "score": "36.63065"}
{"text": "Assessment of tumor radiological response and follow - up .Patients underwent imaging assessment ( quadriphasic CT or dynamic MRI ) one month after TACE in order to evaluate the radiological response according to clinical practice .", "label": "", "metadata": {}, "score": "36.725964"}
{"text": "The CT perfusion parameter , measured by the contrast agent leakage from the intravascular space to extravascular extracellular space , reflects an in vivo dynamic microcirculatory blood volume than the counted vessels on paraffin - embedded tissue specimens .", "label": "", "metadata": {}, "score": "37.403404"}
{"text": "Histology and immunohistochemistry ( IHC ) of HCC and surrounding non - tumor liver parenchyma .Microvessels were counted on a 200\u00d7 field ( 0.62 mm 2 ) .", "label": "", "metadata": {}, "score": "37.645645"}
{"text": "Histology and immunohistochemistry ( IHC ) of HCC and surrounding non - tumor liver parenchyma .Microvessels were counted on a 200\u00d7 field ( 0.62 mm 2 ) .", "label": "", "metadata": {}, "score": "37.645645"}
{"text": "Histological observation of HCC angiogenesis is invasive and , therefore , impractical for repeat measurements .A minimally invasive method by CT perfusion requires high ionizing radiation doses and rapid bolus injection of iodinated contrast agent , which may cause rupturing of vascular walls and a life - threatening allergic reaction .", "label": "", "metadata": {}, "score": "37.753365"}
{"text": "CT Perfusion Imaging .The CT perfusion protocol was adapted from a previous liver perfusion study [ 52 ] using a 64-MDCT scanner ( Aquilion 64 , Toshiba Medical Systems Corporation , Otawara , Japan ) .", "label": "", "metadata": {}, "score": "37.985886"}
{"text": "On the same day of CT perfusion examination , 1 mL of blood was drawn from 21 HCC patients using a heparin rinsed syringe .The blood samples from the controls were also analyzed .", "label": "", "metadata": {}, "score": "38.75406"}
{"text": "CT and MR perfusion parameters of HCCs and automatic selection of arterial input function could be obtained from maps generated using a dedicated software MIStar to evaluate BF of HCC [ 39 ] .", "label": "", "metadata": {}, "score": "39.12191"}
{"text": "An abdominal radiologist who was blinded to the clinical outcome reviewed all CT scans .The CT scans were also evaluated for the presence of portal venous thrombosis and lymphadenopathy .", "label": "", "metadata": {}, "score": "39.193333"}
{"text": "The results of a single - center study carried out by Kooby et al .[26 ] , in which patients treated with chemoembolization or radioembolization were retrospectively compared , suggests that both treatment modalities have similar effectiveness and safety profiles in patients with unresectable HCC .", "label": "", "metadata": {}, "score": "39.644554"}
{"text": "In all patients with a CR , a follow - up CT or MRI at 3 - 6 months was performed .A plain chest X - ray or chest CT were additionally utilized in the follow - up .", "label": "", "metadata": {}, "score": "39.78173"}
{"text": "Because the determinants for therapeutic response of HCC to TACE are complicated and numerous , this study did not take into account these determinants of therapeutic response to TACE , but rather it only correlated the changes in CT perfusion parameters with different treatment responses to TACE .", "label": "", "metadata": {}, "score": "39.810417"}
{"text": "Multivariate analysis of baseline CT parameters showed that prolonged progression - free survival was associated with lower hepatopulmonary shunt fraction , central hypervascularity pattern , and well - defined tumor margins , while shorter progression - free survival was associated with abutment of portal vein by tumor ( Table 5 ) .", "label": "", "metadata": {}, "score": "39.87565"}
{"text": "In our study , the number of cases collected allowed us to divide them into different treatment response groups for observation .In the CR group , CT perfusion imaging of post - TACE lesion displayed complete absence of signal on the CT perfusion maps .", "label": "", "metadata": {}, "score": "41.054512"}
{"text": "After the largest liver tumor was visualized on the non - enhanced CT images by an experienced abdominal radiologist ( C.-P.C. ) with 15 years of experience in liver imaging , a target 3.2-cm scanning length was selected for the CT perfusion study .", "label": "", "metadata": {}, "score": "41.16497"}
{"text": "Computed tomography ( CT ) scans of 23 patients with unresectable primary hepatocellular carcinoma before and after transarterial hepatic selective internal radiotherapy with yttrium-90 microspheres were retrospectively reviewed .", "label": "", "metadata": {}, "score": "41.44094"}
{"text": "Pre - procedural MRI will be performed within four weeks prior to the date of minimization to define HCC lesions by number , volume and location .", "label": "", "metadata": {}, "score": "41.548546"}
{"text": "We acknowledge that the response rate in our study might be overestimated since the assessment of radiological response was usually made with CT , which may underestimate the residual tumor due to the interference of Lipiodol [ 13 ] .", "label": "", "metadata": {}, "score": "41.622177"}
{"text": "The third difference in this study is that we successfully correlated circulating angiogenic factors with in vivo CT perfusion imaging instead of ex vivo fixed tissue sections .", "label": "", "metadata": {}, "score": "41.71655"}
{"text": "[ 27 ] carried out a similar retrospective analysis and concluded that chemoembolization or radioembolization appeared to be equivalent regional therapies for patients with unresectable , nonmetastatic HCC .", "label": "", "metadata": {}, "score": "41.860794"}
{"text": "Moreover , this study hypothesized a predictive value of the MAA SPECT / CT - based dosimetry on tumor response .Dosimetric optimizations could lead in the future to significant improvements of 90 Y radioembolization efficacy .", "label": "", "metadata": {}, "score": "42.08516"}
{"text": "The response to TACE may be evaluated by comparing the difference in perfusion parameters pre- and post - treatment [ 11 , 12 ] .To our knowledge , there are few reports on the application of this technique in evaluating the efficacy of TACE based on the quantitative analysis of perfusion parameters .", "label": "", "metadata": {}, "score": "42.181183"}
{"text": "Repeated radioembolizations of both or single lobes were also performed in a minority of patients in other studies , with a few receiving a third treatment [ 19 , 20 , 24 , 25 ] .", "label": "", "metadata": {}, "score": "42.30169"}
{"text": "CT examination after TACE has been widely used to assess the efficacy of TACE [ 6 ] , but its limitation is that a quantitative evaluation can not be provided and an incomplete lipiodol accumulation may disturb the assessment of viable tumors on contrast - enhanced CT imaging [ 7 ] .", "label": "", "metadata": {}, "score": "42.382717"}
{"text": "Written informed consents were obtained .Patient Selection .We conducted the dynamic contrast - enhanced CT study using a bolus of iodinated contrast agent in patients with HCCs .", "label": "", "metadata": {}, "score": "42.668007"}
{"text": "Radioembolization was performed as a staged procedure .First , the visceral arterial supply was mapped angiographically , vessels posing a risk to nontarget GI structures were embolized , and a shunt study was performed .", "label": "", "metadata": {}, "score": "42.669853"}
{"text": "Twenty - three post - radioembolization 90 Y PET / CT scans were eligible for dose - response analysis , as was reported in part 1 [ 1 ] .", "label": "", "metadata": {}, "score": "43.573265"}
{"text": "Additionally , we compared the perfusion parameters between non - tumor liver parenchyma and HCC using a dedicated CT perfusion imaging with dual vascular data .", "label": "", "metadata": {}, "score": "43.624275"}
{"text": "The examination was repeated in all patients using the same technique before and 4 wk after TACE .Imaging data processing .After image acquisition , the data were transferred to an image processing workstation ( Advantage Windows 4.3 ; GE Medical Systems ) and analyzed using CT Perfusion 3.0 ( GE Medical Systems ) .", "label": "", "metadata": {}, "score": "43.730865"}
{"text": "Patients had a second angiogram , and the radioactive beads were injected in a lobar fashion [ 19 - 21 ] .Computed Tomography Evaluation .", "label": "", "metadata": {}, "score": "44.045692"}
{"text": "This was performed by a direct , i.e. , Gy - to - Gy , comparison between intended tumor mean doses and post - radioembolization tumor mean doses by 90 Y PET , expressed as relative percentage errors .", "label": "", "metadata": {}, "score": "44.493095"}
{"text": "Results .Transarterial chemoembolization was the primary treatment after diagnosis of HCC in 148 patients with a single nodule of HCC who were not eligible for curative treatment ( final study group )", "label": "", "metadata": {}, "score": "44.85559"}
{"text": "Our CT scanning length , using 64-MDCT , is limited to a 3.2 cm , which only allowed the CT perfusion for studying partial tumor of large - sized HCC .", "label": "", "metadata": {}, "score": "45.037037"}
{"text": "The response of the primary tumor to SIRT was evaluated from the CT images using RECIST 1.1 [ 22 ] and MASS criteria [ 23 ] .", "label": "", "metadata": {}, "score": "45.062656"}
{"text": "Safe delivery of the tumoricidal radiation dose requires careful angiogram planning and coil embolization to quantify lung shunting and prevent systemic toxicity , respectively .Diagnostic pretreatment angiogram also serves to identify the hepatic arterial variant anatomy and other coexisting pathologies that might require a different or alternative approach .", "label": "", "metadata": {}, "score": "45.182384"}
{"text": "Tumor and non - target tissue absorbed dose quantification by 90 Y PET is accurate and yields radiobiologically meaningful dose - response information to guide adjuvant or mitigative action .", "label": "", "metadata": {}, "score": "45.239033"}
{"text": "Additional chemoembolization would be given at the same session setting if there was evidence of residual hypervascularity in hepatic arteriograms .Statistical analysis .DSA has been recognized as the gold standard for detection of viable hepatic tumors [ 5 , 7 ] .", "label": "", "metadata": {}, "score": "45.469692"}
{"text": "The contrast - enhanced CT technique is a easier and flexible method to evaluate the whole tumor than measuring MVD on limited specimens [ 49 , 50 ] .", "label": "", "metadata": {}, "score": "45.532257"}
{"text": "[28 ] retrospectively compared 122 HCC patients who received chemoembolization with 123 patients who received radioembolization and concluded both patient groups had similar survival times .", "label": "", "metadata": {}, "score": "45.64292"}
{"text": "In patients in which MRI is contra - indicated or who are not capable of breath holding , contrast enhanced CT will be carried out .", "label": "", "metadata": {}, "score": "45.954266"}
{"text": "Surgical excision remains the preferred treatment for resectable hepatic metastases of neuroendocrine tumors .In cases of more disseminated hepatic disease , transarterial radioembolization with Yttrium-90- ( 90Y- ) labeled microspheres has been demonstrated as a viable option for symptom and locoregional tumor control .", "label": "", "metadata": {}, "score": "45.969376"}
{"text": "Post Processing Measurement of CT Perfusion .Data on the CT perfusion of the target HCC among 21 patients were analyzed at a commercially available workstation ( MIStar , Apollo Medical Imaging , Melbourne , Australia ) by two experienced radiologists ( J.-S.H. and C.-P.C. ) , specializing in liver imaging for more than 14 years .", "label": "", "metadata": {}, "score": "46.115456"}
{"text": "Two patients presented with recurrent HCC after transarterial chemoembolization ( TACE ) or liver surgery .These enrolled patients had no local or systematic therapy at least six month before CT perfusion .", "label": "", "metadata": {}, "score": "46.182518"}
{"text": "Secondary outcomes .1 : Time to Local Progression ( TLP ) . 'Target liver volume ' will be determined with the use of cone - beam CT during the interventional procedure , by implementing the perfusion area of the targeted vessel in relationship to the anatomic localization of the liver lesion(s ) .", "label": "", "metadata": {}, "score": "46.22363"}
{"text": "In addition , we evaluated the radiographic response following SIRT using MASS criteria to identify patients who favorably responded to radioembolization therapy versus those who needed additional therapy .", "label": "", "metadata": {}, "score": "46.301544"}
{"text": "For the assessment of recurrence - free survival , patients were checked at the time of recurrence or death , at liver transplant ( if performed ) or at the last inpatient / outpatient clinical evaluation when no additional information was available ( patients lost to follow - up ) .", "label": "", "metadata": {}, "score": "46.356983"}
{"text": "Follow - up .Patients will undergo structural follow - up for a timeframe of two years post treatment .Each patient will be seen by the treating physician during regular visits to the outpatient clinic , during which laboratory examination will also be performed ( complete blood count , electrolytes , kidney function tests , liver function tests , albumin , Prothrombin time / INR , alpha - fetoprotein ) .", "label": "", "metadata": {}, "score": "46.37329"}
{"text": "However , the results may provide justification for a prospective trial to confirm and further evaluate the response to SIRT determined by MASS criteria .In addition , there may have been technical inconsistencies in CT scanning , subjectivity in CT scan interpretation , and variation in the time after SIRT for obtaining the CT scan after treatment .", "label": "", "metadata": {}, "score": "46.425484"}
{"text": "To the best of our knowledge , the only data on tumor radiological response of conventional TACE in patients with single unresectable HCC is that of Malagari et al .", "label": "", "metadata": {}, "score": "46.454132"}
{"text": "Clin Imaging .[PubMed ] [ DOI ] .Miles KA , Hayball MP , Dixon AK .Functional images of hepatic perfusion obtained with dynamic CT .", "label": "", "metadata": {}, "score": "46.640568"}
{"text": "In the SD group , the perfusion parameters remained unchanged pre- and post - TACE treatment , suggesting a perfusion recovery within the tumor after treatment .", "label": "", "metadata": {}, "score": "46.66838"}
{"text": "In all patients of our study cohort , only one patient who underwent a period of TACE and CT perfusion examinations pre- and post - treatment had treatment response to CR .", "label": "", "metadata": {}, "score": "46.868225"}
{"text": "[ Google Scholar ] .Ippolito , D. ; Sironi , S. ; Pozzi , M. ; Antolini , L. ; Invernizzi , F. ; Ratti , L. ; Leone , E.B. ; Fazio , F. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma : Assessment of tumor - related vascularization .", "label": "", "metadata": {}, "score": "46.918518"}
{"text": "Transarterial chemoembolization is a well - established treatment for HCC and the current guidelines recommend TACE as a first line non - curative treatment for intermediate stage patients with multinodular asymptomatic tumors without vascular invasion or extrahepatic spread [ 1 ] .", "label": "", "metadata": {}, "score": "47.06997"}
{"text": "In the SD group , all CT perfusion parameters were not significantly different pre- and post - TACE .CONCLUSION :Changes in CT perfusion parameters of viable tumors are correlated with different responses of HCC to TACE .", "label": "", "metadata": {}, "score": "47.352745"}
{"text": "Prospective validation trials on tumor predictive dosimetry are now needed , using 90 Y PET - based absorbed doses as a reference .Our tumor dose - response results are only orientating and should be further validated by greater patient numbers and by using more adequate tumor response end points .", "label": "", "metadata": {}, "score": "47.38475"}
{"text": "At univariate analysis , tumor characteristics ( and particularly tumor size ) , some liver function parameters and the achievement of a complete radiological response ( Table 5 ) had a statistical impact on survival .", "label": "", "metadata": {}, "score": "47.394127"}
{"text": "Patients and Tumors .From January 2007 to December 2010 , 63 patients were treated in our center for HCC using intra - arterial 90 Y - microS injections .", "label": "", "metadata": {}, "score": "47.48722"}
{"text": "J. Roentgenol 2008 , 190 , W28-W34 .[ Google Scholar ] .Miles , K.A. Perfusion CT for the assessment of tumour vascularity : Which protocol ?", "label": "", "metadata": {}, "score": "47.69944"}
{"text": "Radiol 2010 , 20 , 1424 - 1430 .[ Google Scholar ] .Goh , V. ; Halligan , S. ; Daley , F. ; Wellsted , D.M. ; Guenther , T. ; Bartram , C.I. Colorectal tumor vascularity : Quantitative assessment with multidetector CT - Do tumor perfusion measurements reflect angiogenesis ?", "label": "", "metadata": {}, "score": "47.90043"}
{"text": "When the interventional radiologist was aware of being unable to achieve complete tumor embolization in only a single TACE session ( for example , due to the use of the maximum dose of Epirubicin allowed ) , the treatment was split into two sessions approximately 1 month apart .", "label": "", "metadata": {}, "score": "47.917"}
{"text": "Pathology examination of the explant in the patient who underwent liver transplantation showed a major histological response in the tumor nodules ( the largest exhibited a totally necrotic aspect ) .", "label": "", "metadata": {}, "score": "48.14998"}
{"text": "After removal of the primary , isolated metastases of neuroendocrine tumors to the liver can be curatively approached by surgical resection with achievable disease - free survival of 42 to 46 months depending on the extent of metastases [ 1 ] .", "label": "", "metadata": {}, "score": "48.36289"}
{"text": "In addition to overall survival , the trial should consider secondary curative surgery after downsizing as a main outcome criterion , similar to studies on liver metastases from colorectal adenocarcinoma [ 33 ] .", "label": "", "metadata": {}, "score": "48.750587"}
{"text": "No attempt was made to obtain a biopsy of the portal thrombus prior to treatment , but triphasic helical computed tomography demonstrated contrast uptake kinetics characteristic of PVTT observed in HCC : arterial enhancement and portal washout .", "label": "", "metadata": {}, "score": "48.75928"}
{"text": "This confirmed the fundamental role of individual clinical judgment in the treatment of HCC .Declarations .Acknowledgements .No specific funding was received connected to the present work .", "label": "", "metadata": {}, "score": "48.772465"}
{"text": "The dose absorbed in the tumour and in the healthy liver were then calculated using the classical formula : .Treatment Procedure .Within 2 weeks of the planning angiography study , the prescribed activity of 90 Y glass microspheres was administered by placing the tip of the delivery catheter in the same anatomic position as that used for the 99mTc - MAA injection .", "label": "", "metadata": {}, "score": "48.84405"}
{"text": "Thus , application of different models to the same data may well yield different perfusion values .It should be emphasized that our results were specific to the method of analysis and the software employed in this study .", "label": "", "metadata": {}, "score": "49.193474"}
{"text": "Conclusion .In conclusion , our results showed TACE to be an effective curative treatment in patients with a single nodule of HCC who were not eligible for curative treatment , supporting the strategy of stage migration for early single HCC .", "label": "", "metadata": {}, "score": "49.23056"}
{"text": "Response to treatment was assessed with Response RECIST 1.1 and Morphology , Attenuation , Size , and Structure ( MASS ) criteria .Results .On the post - SIRT CT , 68 % of tumors demonstrated decreased size ( median decrease of 0.8 cm , . )", "label": "", "metadata": {}, "score": "49.301758"}
{"text": "We were unable to define the exact normal tissue radiation thresholds based on our limited case series .However , greater clarity on this issue shall be gained in the years ahead as post - radioembolization 90 Y PET / CT gains popularity around the world .", "label": "", "metadata": {}, "score": "49.310295"}
{"text": "Tissue quantification .Retrospective absorbed dose quantification by 90 Y PET was performed on the same 23-patient data set as was reported in part 1 [ 1 ] .", "label": "", "metadata": {}, "score": "49.335083"}
{"text": "PubMed View Article .Kim JH , Yoon HK , Kim SY , Kim KM , Ko GY , Gwon DI , Sung KB : Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis .", "label": "", "metadata": {}, "score": "49.596375"}
{"text": "Furthermore , it is not well studied whether CT scans can provide clinically useful objective parameters before or after SIRT in patients with hepatocellular carcinoma and whether the availability of these parameters may improve patient selection and treatment outcome from SIRT .", "label": "", "metadata": {}, "score": "49.62642"}
{"text": "Overall , metastatic neuroendocrine tumors have exhibited modest response to systemic chemotherapy . Streptozocin- and doxorubicin - based protocols achieve response rates of up to 16 % .", "label": "", "metadata": {}, "score": "49.67881"}
{"text": "Tumors were analyzed using cumulative 90 Y DVHs generated by voxel dosimetry .This was performed on a small select group of tumors treated under highly favorable , near - ideal dosimetric conditions to ensure reliable dose - response observations and to assess the best possible accuracy of tumor 99 m Tc MAA SPECT / CT predictive dosimetry .", "label": "", "metadata": {}, "score": "49.777874"}
{"text": "Dose distribution heterogeneity was limited to the size of the reconstructed voxels ; true dose heterogeneity at the microscopic level was not assessed .Mean absorbed doses in tumor vascular thrombosis and gastric and duodenal walls were estimated by 90 Y MIRD macrodosimetry [ 7 , 22 ] .", "label": "", "metadata": {}, "score": "49.91123"}
{"text": "Traditionally based on planar scintigraphy [ 13 , 14 ] , modern predictive dosimetry employs SPECT / CT to tomographically assess the biodistribution of 99 m Tc MAA and to improve its quantitative accuracy [ 6 ] .", "label": "", "metadata": {}, "score": "49.983032"}
{"text": "To this end , we have shown in our highly select tumor data set that the intended tumor mean doses by 99 m Tc MAA SPECT / CT predictive dosimetry correlated well with post - radioembolization doses by 90 Y PET .", "label": "", "metadata": {}, "score": "49.98996"}
{"text": "The hepatic artery will be catheterized and the 90 Y - microspheres will be administered from the exact same microcatheter position as where the 99 m Tc - MAA was administered .", "label": "", "metadata": {}, "score": "50.009308"}
{"text": "J. Radiol 2003 , 76 , S36-S42 .[ Google Scholar ] .Cuenod , C.A. ; Fournier , L. ; Balvay , D. ; Guinebretiere , J.M. Tumor angiogenesis : Pathophysiology and implications for contrast - enhanced MRI and CT assessment .", "label": "", "metadata": {}, "score": "50.143635"}
{"text": "In clinical practice , however , patients with a single tumor unsuitable for curative treatment are usually treated with transarterial chemoembolization ( TACE ) on the basis of a clinical judgment .", "label": "", "metadata": {}, "score": "50.227985"}
{"text": "In part 2 of our two - part retrospective report , we focus on post - radioembolization 90 Y PET quantification on the same patient cohort as was reported in part 1 [ 1 ] .", "label": "", "metadata": {}, "score": "50.280914"}
{"text": "For initial localization of the tumor , a CT scan of the abdomen was performed without contrast medium during a breath hold at the end of expiration .", "label": "", "metadata": {}, "score": "50.576057"}
{"text": "Radioembolization offers a novel way to treat the nonresectable , liver predominant hepatic malignancies with better tumor response and overall progression - free survival rates .", "label": "", "metadata": {}, "score": "50.579224"}
{"text": "Further histological research is needed to prove this speculation .In addition , many CT perfusion analyses were performed using a single arterial input [ 8 , 9 , 15 ] , but the liver has a dual arterial - portal blood supply , and the tumor and portal vein could not be consistently included .", "label": "", "metadata": {}, "score": "50.672768"}
{"text": "The differences between continuous variables ( tumor size and attenuation ) before and after SIRT were dichotomized at the median for survival analysis .Changes between CT parameters before and after treatment were analyzed with Wilcoxon Signed - Rank Test ( continuous variables ) or Fisher 's Exact Test ( categorical variables ) .", "label": "", "metadata": {}, "score": "50.7452"}
{"text": "These results suggested that BF in HCC was differentiated from that in the surrounding liver parenchyma .To examine if quantitative CT perfusion parameters was correlated with MVD , which was used as an indicator for evaluation of tumor angiogenesis , immunohistochemistry ( IHC ) with anti - CD31 , a vascular marker , was conducted .", "label": "", "metadata": {}, "score": "50.892155"}
{"text": "All dose - response results of non - target tissue were serendipitously obtained in cases of unintended non - target shunting of 90 Y resin microspheres due to unexpected vascular stasis and microsphere reflux during 90 Y radioembolization .", "label": "", "metadata": {}, "score": "50.988937"}
{"text": "For patients with locally advanced , liver restricted disease ( BCLC intermediate stage ) , transarterial loco regional treatment modalities offer palliative treatment options .These therapies exploit the dual blood supply to the liver .", "label": "", "metadata": {}, "score": "51.004005"}
{"text": "Safety was assessed according to the Common Terminology Criteria for Adverse Events CTCAEv3.0 criteria [ 23 ] .Pathologic analysis of resected specimens in secondly operated patients was performed .", "label": "", "metadata": {}, "score": "51.02737"}
{"text": "Imaging 2010 , 35 , 622 - 628 .[ Google Scholar ] .Sahani , D.V. ; Holalkere , N.S. ; Mueller , P.R. ; Zhu , A.X. Advanced hepatocellular carcinoma : CT perfusion of liver and tumor tissue - Initial experience .", "label": "", "metadata": {}, "score": "51.03212"}
{"text": "Curative treatment options include liver transplant , resection , and ablation [ 4 ] .However , approximately two thirds of patients are not candidates for curative therapy when diagnosed [ 5 ] .", "label": "", "metadata": {}, "score": "51.16584"}
{"text": "Our series confirmed the safety of this treatment , a further argument favoring its efficacy on the thrombosis .Using the EASL criteria , the tumor was controlled in 88.9 % of our patients at three months [ 19 ] ; the thrombosis regressed in the majority ( 11/18 ) .", "label": "", "metadata": {}, "score": "51.372414"}
{"text": "AIM : To prospectively assess the changes in parameters of computed tomography ( CT ) perfusion pre- and post - transarterial chemoembolization ( TACE ) of hepatocellular carcinoma ( HCC ) in different treatment response groups , and to correlate the changes with various responses of HCC to TACE .", "label": "", "metadata": {}, "score": "51.431717"}
{"text": "In the PR group of HCC , after TACE treatment , the change in perfusion parameters was consistent with previous findings [ 11 , 16 ] .", "label": "", "metadata": {}, "score": "51.584564"}
{"text": "Transarterial chemoembolization was performed once in 80 patients ( 54 % ) , twice in 44 patients ( 30 % ) , three times in 17 patients ( 11 % ) and 4 times in 7 patients ( 5 % ) .", "label": "", "metadata": {}, "score": "51.59734"}
{"text": "10.1007/s12149 - 011 - 0499 - 6 View Article .Kao YH , Tan EH , Teo TK , Ng CE , Goh SW : Imaging discordance between hepatic angiography versus Tc-99m - MAA SPECT / CT : a case series , technical discussion and clinical implications .", "label": "", "metadata": {}, "score": "51.76721"}
{"text": "Collection of informed consents was waived given the retrospective nature of the study .Methods .TACE protocol and technical procedure .Before treatment , baseline clinical evaluation , laboratory tests , chest X - ray and tumor stage were assessed in all patients .", "label": "", "metadata": {}, "score": "51.949196"}
{"text": "Pretreatment features including well - defined tumor margins ( Figures 5(a ) and 5(b ) ) , central hypervascularity pattern , and lower hepatopulmonary shunt fraction were associated with improved progression - free survival ( Table 5 ) .", "label": "", "metadata": {}, "score": "51.95839"}
{"text": "Study participants .Previous local therapy for HCC will not be a contraindication if at least one measurable target lesion is present , which has not been treated previously .", "label": "", "metadata": {}, "score": "52.20769"}
{"text": "View Article .Altman DG , Bland JM : Treatment allocation by minimisation .BMJ 2005 , 330 : 843 .PubMed View Article .Cardiovasc Intervent Radiol 2011 , 34 : 1074 - 1079 .", "label": "", "metadata": {}, "score": "52.219955"}
{"text": "For better visualization of HCC before contrast - enhanced CT scan , most of our patients had only one solitary large HCC , so data analysis from variable sized HCC are required in the future .", "label": "", "metadata": {}, "score": "52.250153"}
{"text": "Regarding tumoral dosimetry , this study brings an interesting result as controlled lesions had higher dosimetry with a median dose to the tumor 284.5 Gy ( 194 - 393.9 ) .", "label": "", "metadata": {}, "score": "52.252346"}
{"text": "[PubMed ] [ DOI ] .Fournier LS , Cuenod CA , de Bazelaire C , Siauve N , Rosty C , Tran PL , Frija G , Clement O. Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent .", "label": "", "metadata": {}, "score": "52.260727"}
{"text": "271 - 279 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . A. Kennedy , W. Dezarn , P. McNeillie , et al . , \" Fractionation , dose selection , and response of hepatic metastases of neuroendocrine tumors after 90Y - microsphere brachytherapy , \" Brachytherapy , vol .", "label": "", "metadata": {}, "score": "52.28096"}
{"text": "Also , significant surgical morbidity and mortality as well as the unpredictable natural history of malignant neuroendocrine neoplasms has to be considered [ 2 ] .", "label": "", "metadata": {}, "score": "52.28804"}
{"text": "The results of this study are similar to previously described findings in patients with metastatic renal cell carcinoma [ 23 ] .A previous study of liver metastases from colorectal cancer showed that RECIST criteria and tumor density were less useful in assessing the response to yttrium-90 radioembolization treatment than 18 F - fluorodeoxyglucose positron emission tomography / CT tomography [ 34 ] .", "label": "", "metadata": {}, "score": "52.358383"}
{"text": "PubMed View Article .Georgiades CS , Hong K , D'Angelo M , Geschwind JF : Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis .", "label": "", "metadata": {}, "score": "52.503143"}
{"text": "Technically , multiple circulating angiogenic factors can be simultaneously analyzed using a recently developed multiplex immunoassay technique with a minimal amount of blood samples , providing a much faster test than conventional enzyme - linked immunosorbent assay ( ELISA ) techniques [ 29 ] .", "label": "", "metadata": {}, "score": "52.597847"}
{"text": "The specific aim of our tumor analysis was to evaluate the best possible performance of tumor predictive dosimetry planned by 99 m Tc MAA SPECT / CT .", "label": "", "metadata": {}, "score": "52.663563"}
{"text": "Such changes may have no major effect on overall tumor size and frequently are read as stable disease or even progression by RECIST criteria .These patterns of tumoral changes have been reported in HCC and also with imatinib , sorafenib , and sunitinib use in other tumor types , such as non - small - cell lung cancer , renal cell carcinomas , and gastrointestinal stromal tumors [ 32 , 33 ] .", "label": "", "metadata": {}, "score": "52.681923"}
{"text": "Previous studies have shown that CT perfusion is a feasible technique to assess the hemodynamic characteristics of HCC [ 9 , 13 ] .Wang et al . demonstrated BF in HCCs and surrounding liver parenchyma in a single - vessel CT perfusion model [ 40 ] , which differs from our dual - vessel model .", "label": "", "metadata": {}, "score": "52.749054"}
{"text": "The primary outcome of the study will be time to progression .Kaplan - Meier analysis will be performed to compare time to progression between treatment arms and difference in TTP will be tested by using the log rank test .", "label": "", "metadata": {}, "score": "52.82923"}
{"text": "Conclusion .In patients with unresectable hepatocellular carcinoma , pretreatment CT parameters may predict favorable response to SIRT and improve patient selection .Introduction .Hepatocellular carcinoma is the third leading cause of cancer mortality worldwide [ 1 ] .", "label": "", "metadata": {}, "score": "53.028183"}
{"text": "When the 99 m Tc - MAA scintigraphy has a favorable outcome , patients will be readmitted to the hospital for the treatment session within two weeks .", "label": "", "metadata": {}, "score": "53.043343"}
{"text": "J Hepatol 2012 , 56 : 886 - 892 .PubMed View Article .Terzi E , Golfieri R , Piscaglia F , Galassi M , Dazzi A , Leoni S , Giampalma E , Renzulli M , Bolondi L : Response rate and clinical outcome of HCC after first and repeated cTACE performed \" on demand \" .", "label": "", "metadata": {}, "score": "53.123142"}
{"text": "A 90 Y PET VOI of the activity within the portal vein tumor thrombus was defined by volumetric isocontour thresholding , visually constrained to its anatomical margins as seen on the catheter - directed CT angiography .", "label": "", "metadata": {}, "score": "53.127"}
{"text": "Patients with bilateral thrombi or extension to the extrahepatic trunk would be poor indications due to the unfavorable benefit - risk ratio .Conflict of Interests . E. Garin is a consultant for Nordion SA , J. L. Raoul is a consultant for Nordion SA and Bayer Pharmaceutical .", "label": "", "metadata": {}, "score": "53.297035"}
{"text": "[ Google Scholar ] .Radiology 2004 , 233 , 191 - 199 .[ Google Scholar ] .Chen , Y. ; Zhang , J. ; Dai , J. ; Feng , X. ; Lu , H. ; Zhou , C. Angiogenesis of renal cell carcinoma : Perfusion CT findings .", "label": "", "metadata": {}, "score": "53.374325"}
{"text": "MRI will be performed on 1.5-T scanners using a spoiled gradient - echo T1-weighted sequence and fast spin - echo T2-weighted sequence with fat suppression .", "label": "", "metadata": {}, "score": "53.558044"}
{"text": "Our results may change this point in the next future .Another confirmation has been brought by Chiesa et al .[ 32 ] who founded a median dose of the responding lesion of 431 Gy as against only 199 Gy for the nonresponding lesion ( . )", "label": "", "metadata": {}, "score": "53.569527"}
{"text": "Discussion .Overall , the available studies demonstrate effective and safe use of radioembolization for liver dominant disease in mNET .There is a positive effect on symptoms , quality of life , response criteria , and survival in various stages of progression , which is mirrored in the recommendations of the Radioembolization Brachytherapy Oncology Consortium [ 26 ] .", "label": "", "metadata": {}, "score": "53.71925"}
{"text": "PubMed View Article .Am J Transplant 2009 , 9 : 1920 - 1928 .PubMed View Article .Radiology 2010 , 255 : 955 - 965 .", "label": "", "metadata": {}, "score": "53.74308"}
{"text": "J Vasc Interv Radiol 2010 , 21 : 224 - 230 .PubMed View Article .Carr BI , Kondragunta V , Buch SC , Branch RA : Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma : a two - cohort study .", "label": "", "metadata": {}, "score": "53.83446"}
{"text": "Immunohistochemistry ( IHC ) and Tumor Vascularity Counting .To demonstrate the relationship between the CT perfusion parameters and vascular density measurement of HCC , we performed IHC of HCC tissue slides in eight patients for CD31 staining , which has been considered as a method for histologically quantifying small blood vessels .", "label": "", "metadata": {}, "score": "53.870598"}
{"text": "Hepatocellular carcinoma Transarterial chemoembolization Tumor radiological response .Background .Curative treatment is considered the first choice treatment for patients with single hepatocellular carcinoma ( HCC ) according to the international guidelines [ 1 ] .", "label": "", "metadata": {}, "score": "53.894913"}
{"text": "All patients underwent laboratory , imaging , and clinical assessment after 4 to 6 weeks , with repeated treatment if necessary .The majority of patients in both groups had Child - Pugh class A disease and had undergone resection of the primary tumor ; a minority ( 20 % to 23 % ) had previously undergone hepatic resection , Dr. Hong said .", "label": "", "metadata": {}, "score": "54.018784"}
{"text": "There was no significant correlation between the level of circulating AFP and CT perfusion parameters of HCCs , such as total BF ( Figure 4A ) .", "label": "", "metadata": {}, "score": "54.277473"}
{"text": "Br J Radiol 1994 , 67 : 136 - 139 .10.1259/0007 - 1285 - 67 - 794 - 136 View Article .Kennedy AS , Nutting C , Coldwell D , Gaiser J , Drachenberg C : Pathologic response and microdosimetry of 90 Y microspheres in man : review of four explanted whole livers .", "label": "", "metadata": {}, "score": "54.31102"}
{"text": "The therapeutic efficacy of TACE has been evaluated by various imaging modalities .Digital subtraction angiography ( DSA ) is probably the most sensitive and effective imaging modality [ 4 , 5 ] .", "label": "", "metadata": {}, "score": "54.401596"}
{"text": "The definitions of the CT perfusion parameters and the models were used for generating functional CT perfusion maps .The commonly used two - compartment model regards the extracellular space and plasma as two compartments that are individually well mixed [ 53 ] .", "label": "", "metadata": {}, "score": "54.456093"}
{"text": "The primary difference between the previous studies and the current study is that we utilized multiplexed bead - based immunoassays for detecting the four circulating angiogenic factors in a clinical study .", "label": "", "metadata": {}, "score": "54.478554"}
{"text": "Collection of tumor marker data , for example , Chromogranin A , as well as functional parameters , for example , PET , may help to overcome some of these shortcomings .", "label": "", "metadata": {}, "score": "54.482624"}
{"text": "Hsu et al . reported no significant relationships between the circulating VEGF level and the vascularity of HCCs on power Doppler ultrasonography following thalidomide therapy [ 44 ] .", "label": "", "metadata": {}, "score": "54.540672"}
{"text": "Bremsstrahlung imaging was performed to confirm pretreatment MAA SPECT data for tumor targeting .Evaluation and Followup .Clinical and biological evaluations were done after 1 and 4 weeks and then every 3 months .", "label": "", "metadata": {}, "score": "54.549892"}
{"text": "According to the current guidelines , TACE is the first line non - curative treatment for intermediate stage patients [ 1 ] .No evidence of a beneficial impact of TACE in patients with single HCC is reported in the guidelines since the trials upon which the guidelines are built [ 15 ] , for the most part , included patients with multiple nodules of HCC .", "label": "", "metadata": {}, "score": "54.584007"}
{"text": "PubMed ] [ DOI ] .Miles KA .Perfusion CT for the assessment of tumour vascularity : which protocol ?Br J Radiol .2003 ; 76 Spec No 1 : S36-S42 .", "label": "", "metadata": {}, "score": "54.58429"}
{"text": "Twenty - one patients with HCC received 21-phase liver imaging using a 64-slice CT .Total BF , arterial BF , portal BF , arterial fraction ( arterial BF / total BF ) of the HCC and surrounding liver parenchyma , and HCC - parenchyma ratio were measured using a dual - vessel model .", "label": "", "metadata": {}, "score": "54.67887"}
{"text": "Radiol 2006 , 41 , 15 - 21 .[ Google Scholar ] .Kothari , M. ; Guermazi , A. ; White , D. ; Suhy , J. ; Reinhold , C. Imaging in antiangiogenesis trial : A clinical trials radiology perspective .", "label": "", "metadata": {}, "score": "54.715046"}
{"text": "[PubMed ] [ DOI ] .Kan Z , Kobayashi S , Phongkitkarun S , Charnsangavej C. Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model .", "label": "", "metadata": {}, "score": "54.737442"}
{"text": "The first angiogram and follow - up angiograms in the latter sessions 4 - 5 wk and 8 - 9 wk following the first TACE were compared .", "label": "", "metadata": {}, "score": "54.934814"}
{"text": "PubMed View Article .Cescon M , Vetrone G , Grazi GL , Ramacciato G , Ercolani G , Ravaioli M , Del Gaudio M , Pinna AD : Trends in perioperative outcome after hepatic resection : analysis of 1500 consecutive unselected cases over 20 years .", "label": "", "metadata": {}, "score": "54.999084"}
{"text": "PubMed View Article .Luo J , Guo RP , Lai EC , Zhang YJ , Lau WY , Chen MS , Shi M : Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis : a prospective comparative study .", "label": "", "metadata": {}, "score": "55.0261"}
{"text": "For that reason , although RECIST has been an established tool for assessment of tumor response to conventional cytotoxic chemotherapy , its limitations in assessing the antitumor activity of certain liver - directed therapies and molecularly targeted treatments such as with antiangiogenic agents are increasingly recognized [ 24 - 27 ] .", "label": "", "metadata": {}, "score": "55.23191"}
{"text": "( a )Catheter - directed CT angiogram of the right inferior adrenal artery delineates the targeted right adrenal tumor measuring 10.1 \u00d7 6.3 cm .", "label": "", "metadata": {}, "score": "55.34243"}
{"text": "Under near - ideal dosimetric conditions , there was excellent correlation between intended tumor mean doses by predictive dosimetry and those by 90 Y PET , with a low median relative error of +3.8 % ( 95 % confidence interval , -1.2 % to +13.2 % ) .", "label": "", "metadata": {}, "score": "55.41159"}
{"text": "The distribution of 99 m Tc - MAA will be visualized by whole body planar imaging and single - photon emission computed tomography ( SPECT - CT ) , including low dose computer tomography of the abdomen .", "label": "", "metadata": {}, "score": "55.533302"}
{"text": "268 - 275 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . S. Gupta , M. M. Johnson , R. Murthy et al . , \" Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors : variables affecting response rates and survival , \" Cancer , vol .", "label": "", "metadata": {}, "score": "55.546715"}
{"text": "\" Essentially all patients developed some element of a postembolization syndrome , but most were self - limiting with conservative measures , \" he said .", "label": "", "metadata": {}, "score": "55.55812"}
{"text": "Partial patency of the portal vein was observed in eight patients and complete involution of the thrombus in three others .For 15 of the 18 patients ( 83.3 % ) , there was a change in the aspect of the thrombus after treatment : objective decrease in contrast uptake due to devascularization of the portal tumor buds .", "label": "", "metadata": {}, "score": "55.57735"}
{"text": "These patients showing advanced diseases ( PVTT ) but involving only one lobe were treated with the intention to downstage their disease to a curative surgical treatment ( transplantation or resection ) .", "label": "", "metadata": {}, "score": "55.69387"}
{"text": "Oncol 2002 , 20 , 4368 - 4380 .[ Google Scholar ] .Wang , J.H. ; Min , P.Q. ; Wang , P.J. ; Cheng , W.X. ; Zhang , X.H. ; Wang , Y. ; Zhao , X.H. ; Mao , X.Q. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma .", "label": "", "metadata": {}, "score": "55.712112"}
{"text": "Tumor response was reported using the lesion - specific modified Response Evaluation Criteria in Solid Tumors [ 28 ] .In addition , we defined a ' minor response ' as any tumor size reduction which does not fulfill the criteria for a partial response .", "label": "", "metadata": {}, "score": "55.97209"}
{"text": "View at Google Scholar \u00b7 View at Scopus Abstract .Background .Patients with single hepatocellular carcinoma ( HCC ) usually undergo transarterial chemoembolization ( TACE ) if they are not candidates for curative surgical or ablative therapy .", "label": "", "metadata": {}, "score": "55.99443"}
{"text": "A more recent Cochrane review and meta - analysis concluded that there is no firm evidence to support or refute TACE in patients with unresectable HCC [ 15 ] .", "label": "", "metadata": {}, "score": "56.15485"}
{"text": "29 , no .4 , pp .522 - 529 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. S. K. Lu , N. C. Yu , S. S. Raman et al . , \" Radiofrequency ablation of hepatocellular carcinoma : treatment success as defined by histologic examination of the explanted liver , \" Radiology , vol .", "label": "", "metadata": {}, "score": "56.235466"}
{"text": "Rev 1999 , 79 , 1283 - 1316 .[ Google Scholar ] .Luo , M.Y. ; Shan , H. ; Jiang , Z.B. ; Li , L.F. ; Huang , H.Q. Study on hepatocellular carcinoma - associated hepatic arteriovenous shunt using multidetector CT .", "label": "", "metadata": {}, "score": "56.336746"}
{"text": "Transarterial radioembolization ( TARE ) or selective internal radiotherapy ( SIRT ) with Yttrium-90 microspheres represents a further viable option in the treatment arsenal for nonresectable liver metastases of both functional and nonfunctional NETs .", "label": "", "metadata": {}, "score": "56.55418"}
{"text": "For selective transarterial chemoembolization , the tip of the microcatheter was placed into the hepatic arterial branch afferent to the segment where the tumor was located .", "label": "", "metadata": {}, "score": "56.55625"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . A. S. Kennedy , W. A. Dezarn , P. McNeillie et al . , \" Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y - microspheres : early results in 148 patients , \" American Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "56.600903"}
{"text": "PubMed ] [ DOI ] .Ngan H , Lai CL , Fan ST , Lai EC , Yuen WK , Tso WK .Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam .", "label": "", "metadata": {}, "score": "56.606003"}
{"text": "This is a pragmatic , multicenter , randomized controlled trial .Patients will be recruited after referral by their hepatologist or another treating physician .Treatment allocation will be performed by minimization , which is a valid alternative to standard randomization to ensure balance between groups for several prognostic factors [ 30 ] .", "label": "", "metadata": {}, "score": "56.635033"}
{"text": "[ Google Scholar ] .Bertolotto , M. ; Pozzato , G. ; Croce , L.S. ; Nascimben , F. ; Gasparini , C. ; Cova , M.A. ; Tiribelli , C. Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion : Preliminary results .", "label": "", "metadata": {}, "score": "56.639214"}
{"text": "The secondary end points were tumor response at 1 month , local and distant recurrence rates , time to recurrence and impact of TACE on liver function .", "label": "", "metadata": {}, "score": "56.686634"}
{"text": "The issue of proper patient selection for retreatment after TACE has become more stringent in recent years due to the availability of alternative treatments such as sorafenib [ 33 ] , and radioembolization [ 24 ] .", "label": "", "metadata": {}, "score": "56.799347"}
{"text": "Results are summarized in Additional file 1 : Table S1 .Discussion .With its superior image resolution and quantitative capability , 90 Y PET / CT is a powerful tool to be integrated into the 90 Y radioembolization workflow .", "label": "", "metadata": {}, "score": "56.94769"}
{"text": "Cardiovasc Intervent Radiol 2008 , 31 : 1141 - 1149 .PubMed View Article .Malagari K , Chatzimichael K , Alexopoulou E , Kelekis A , Hall B , Dourakis S , Delis S , Gouliamos A , Kelekis D : Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads : results of an open - label study of 62 patients .", "label": "", "metadata": {}, "score": "57.054966"}
{"text": "Future studies may include prospective investigation of the accuracy of MASS criteria as a possible predictor of primary tumor response after SIRT in patients with hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "57.066643"}
{"text": "View Article .Sorensen JB , Klee M , Palshof T , Hansen HH : Performance status assessment in cancer patients .An inter - observer variability study .", "label": "", "metadata": {}, "score": "57.107185"}
{"text": "Based on these results , we deemed it feasible to assume all tumor activities quantified by 90 Y PET to have negligible error for the purposes of this study .", "label": "", "metadata": {}, "score": "57.14048"}
{"text": "The procedure will be carried out over two separate sessions : a work - up session and a treatment session .Meticulous work - up is very important because it determines the overall safety of the treatment .", "label": "", "metadata": {}, "score": "57.21209"}
{"text": "The median dose of yttrium-90 glass microspheres administered to the patient was 2.0 GBq ( 0.6 - 4.3 ) .Comparing the radiographic features of the CT scan obtained at median 1.5 months after SIRT to the CT scan obtained at baseline , most tumors margins were unchanged , and almost half of the number of tumors ( 48 % ) had increased percentage of necrosis ( .", "label": "", "metadata": {}, "score": "57.331894"}
{"text": "In terms of secondary outcomes , we will analyze time to local progression and overall survival by means of Kaplan Meier analysis , and test differences between the two arms with log rank test .", "label": "", "metadata": {}, "score": "57.35646"}
{"text": "This in conjunction with other tumor characteristics such as hepatopulmonary shunt fraction may enable the stratification of patients and improve selection of patients who may benefit from SIRT and serve as biomarkers in predicting response to SIRT .", "label": "", "metadata": {}, "score": "57.37146"}
{"text": "Taking a hypothetical loss to follow - up of 2 % into account in both treatment arms , based on earlier experience with this patient group , still gives a power of 80 % if 70 patients per treatment arm are included ( Alpha Risk remains 5 % ) .", "label": "", "metadata": {}, "score": "57.49133"}
{"text": "Liver Transpl 2010 , 16 : 658 - 667 .PubMed .Llovet JM , Bru C , Bruix J : Prognosis of hepatocellular carcinoma : the BCLC staging classification .", "label": "", "metadata": {}, "score": "57.493374"}
{"text": "Followup was less than 1 year for six patients ; four of them were dead .Survival rates at 6 months and 1 year were .", "label": "", "metadata": {}, "score": "57.493496"}
{"text": "The mRECIST overall response assessment includes the evaluation of target lesions response , non - target lesions response and the occurrence of new lesions .The baseline for calculation of TTP will be the date of minimization .", "label": "", "metadata": {}, "score": "57.521755"}
{"text": "J. Radiol 2003 , 76 , S92-S96 .[ Google Scholar ] .Hsu , C. ; Chen , C.N. ; Chen , L.T. ; Wu , C.Y. ; Hsieh , F.J. ; Cheng , A.L. Effect of thalidomide in hepatocellular carcinoma : Assessment with power doppler US and analysis of circulating angiogenic factors .", "label": "", "metadata": {}, "score": "57.603233"}
{"text": "PubMed ] [ DOI ] .Sahani DV , Holalkere NS , Mueller PR , Zhu AX .Advanced hepatocellular carcinoma : CT perfusion of liver and tumor tissue -- initial experience .", "label": "", "metadata": {}, "score": "57.681538"}
{"text": "TACE technique .All TACE procedures were performed by one experienced interventional radiologist .Diagnostic arteriogram of the common , right or left hepatic artery was obtained in all patients prior to TACE .", "label": "", "metadata": {}, "score": "57.68342"}
{"text": "Background .In patients with hepatocellular carcinoma , selection criteria for transarterial hepatic selective internal radiotherapy are imprecise .Additionally , radiographic parameters to predict outcome of transarterial hepatic selective internal radiotherapy have not been fully characterized .", "label": "", "metadata": {}, "score": "57.718674"}
{"text": "10.2967/jnumed.110.075861 View Article . D'ArienzoM , Chiaramida P , Chiacchiararelli L , Coniglio A , Cianni R , Salvatori R , Ruzza A , Scopinaro F , Bagni O : 90 Y PET - based dosimetry after selective internal radiotherapy treatments .", "label": "", "metadata": {}, "score": "57.74722"}
{"text": "Nonetheless , the current patient selection criteria for SIRT are imprecise , and there is limited information available about the effect of SIRT on computed tomography ( CT ) characteristics of hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "57.925377"}
{"text": "PubMed .Liapi E , Georgiades CC , Hong K , Geschwind JF : Transcatheter arterial chemoembolization : current technique and future promise .Tech Vasc Interv Radiol 2007 , 10 : 2 - 11 .", "label": "", "metadata": {}, "score": "57.942894"}
{"text": "[PubMed ] [ DOI ] .Tsushima Y , Funabasama S , Aoki J , Sanada S , Endo K. Quantitative perfusion map of malignant liver tumors , created from dynamic computed tomography data .", "label": "", "metadata": {}, "score": "57.961544"}
{"text": "4 , pp .341 - 348 , 2011 .View at Publisher \u00b7 View at Google Scholar . A. T. Ruutiainen , M. C. Soulen , C. M. Tuite et al . , \" Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "58.013004"}
{"text": "PubMed View Article .Wigmore SJ , Redhead DN , Thomson BN , Currie EJ , Parks RW , Madhavan KK , Garden OJ : Postchemoembolisation syndrome - tumour necrosis or hepatocyte injury ?", "label": "", "metadata": {}, "score": "58.014862"}
{"text": "Symptom improvement and Chromogranin A decrease at 6 months were seen in 50 % and 41 % of cases , respectively .59 % of patients remained alive at 37 \u00b1 2 months , with 12 patients without hepatic recurrence at 33.3 \u00b1 2.3 months [ 20 ] .", "label": "", "metadata": {}, "score": "58.044678"}
{"text": "The secondary aims were tumor response , local and distant recurrence rates , time to recurrence and the impact of TACE on liver function .Methods .", "label": "", "metadata": {}, "score": "58.075798"}
{"text": "Discussion .PVTT is a poor prognostic factor for HCC .According to the BCLC classification [ 4 ] , patients with PVT have advanced - stage disease , limiting options for surgery and intra - arterial therapy .", "label": "", "metadata": {}, "score": "58.09857"}
{"text": "[ Google Scholar ] .Li , Z.P. ; Meng , Q.F. ; Sun , C.H. ; Xu , D.S. ; Fan , M. ; Yang , X.F. ; Chen , D.Y. Tumor angiogenesis and dynamic CT in colorectal carcinoma : Radiologic - pathologic correlation .", "label": "", "metadata": {}, "score": "58.137077"}
{"text": "The two other patients did not meet the transplantation criteria but were eligible for surgical resection .One had a right hepatectomywhile the other was discovered a second HCC during the surgery that contraindicated the programmed hepatectomy .", "label": "", "metadata": {}, "score": "58.14099"}
{"text": "The largest prospective study to date included 291 HCC patients that were treated with 90 Y - RE [ 25 ] .In intermediate stage patients ( BCLC stage B ) median time to progression was 13.3 months ( Child - Pugh A , 13.3 months and Child - Pugh B , 17.4 months ) and median survival was 17.2 months ( Child - Pugh A , 17.3 months and Child - Pugh B , 13.5 months ) .", "label": "", "metadata": {}, "score": "58.162575"}
{"text": "The study was approved by the Institutional Review Board .Clinical Evaluation .The electronic medical records were reviewed for demographic , clinical , radiographic , and pathologic information before and after SIRT .", "label": "", "metadata": {}, "score": "58.252815"}
{"text": "The BCLC staging system includes the ECOG PS [ 12 ] evaluation regarding the assessment of tumor stage .In patients with HCC , the classic determination of PS is not able to differentiate between cancer- or cirrhosis- related symptoms [ 16 ] and the subjective assessment of \" how the patient feels \" can be related to cirrhosis as well as to cancer .", "label": "", "metadata": {}, "score": "58.253685"}
{"text": "No patient developed extrahepatic spread before or concurrently with the detection of local or intrahepatic relapse .The overall recurrence rate in patients with complete response was 27 % , 42 % and 65 % at 6 , 12 and 24 months , respectively .", "label": "", "metadata": {}, "score": "58.46351"}
{"text": "View at Google Scholar .T. K. Rhee , R. J. Lewandowski , D. M. Liu et al . , \" 90Y radioembolization for metastatic neuroendocrine liver tumors : preliminary results from a multi - institutional experience , \" Annals of Surgery , vol .", "label": "", "metadata": {}, "score": "58.52324"}
{"text": "Chemo / Radioembolization Both Effective for Liver Mets .Locoregional therapies have become increasingly attractive options for treating hepatic metastases and work in part by exploiting the dual blood supply of the liver , said lead author Kelvin Hong , MD , of the Johns Hopkins University School of Medicine .", "label": "", "metadata": {}, "score": "58.590305"}
{"text": "\" The single - institution , retrospective study compared transarterial chemoembolization ( TACE ) with radioembolization in patients with liver - dominant metastatic colorectal cancer refractory to third - line chemotherapy .", "label": "", "metadata": {}, "score": "58.68459"}
{"text": "[ Google Scholar ] .Wang , J. ; Chen , L.T. ; Tsang , Y.M. ; Liu , T.W. ; Shih , T.T. Dynamic contrast - enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent : A preliminary study .", "label": "", "metadata": {}, "score": "58.714756"}
{"text": "[ Google Scholar ] .Yang , H.F. ; Du , Y. ; Ni , J.X. ; Zhou , X.P. ; Li , J.D. ; Zhang , Q. ; Xu , X.X. ; Li , Y. Perfusion computed tomography evaluation of angiogenesis in liver cancer .", "label": "", "metadata": {}, "score": "58.74819"}
{"text": "In case progressive disease is determined during follow - up , patients have reached the study endpoint and will be treated according to best medical practice .", "label": "", "metadata": {}, "score": "58.74835"}
{"text": "Primary outcome will be time to progression .Secondary outcomes will be overall survival , tumor response according to the modified RECIST criteria , toxicities / adverse events , treatment related effect on total liver function , quality of life , treatment - related costs and cost - effectiveness .", "label": "", "metadata": {}, "score": "58.77574"}
{"text": "For technically successful cases without visually significant discordant biodistribution between 99 m Tc MAA and 90 Y resin microspheres , a direct ' Gy - to - Gy ' comparison of intended doses by 99 m Tc MAA SPECT / CT predictive dosimetry versus post - radioembolization doses by microsphere biodistribution analysis has not yet been performed to date .", "label": "", "metadata": {}, "score": "58.836708"}
{"text": "We did not perform absorbed dose quantification of the non - tumorous liver or lungs as these are regions of much lower 90 Y radioconcentration which may require further research and technical considerations on its quantitative accuracy by 90 Y PET [ 39 ] .", "label": "", "metadata": {}, "score": "58.880337"}
{"text": "Findings with a p -value of less than 0.05 were considered statistically significant .Conclusions .The three circulating angiogenic factors ( IL-6 , IL-8 , and VEGF ) could predict HCC existence by a simple multiplex bead array assay .", "label": "", "metadata": {}, "score": "58.909832"}
{"text": "Briefly , this software allowed us to generate semiautomatically volume of interest ( VOI ) in the liver and tumor by means of an isocontour definition method .", "label": "", "metadata": {}, "score": "58.912544"}
{"text": "A significant negative impact on liver function was observed the day after TACE treatment ( Table 4 ) .Table 4 .Liver function parameters of the whole patient cohort before and one day after TACE procedure .", "label": "", "metadata": {}, "score": "59.028156"}
{"text": "We used the venous injection rate of 3.5 mL / s to avoid vessels rupture and leakage of contrast agent in this study .The model fitting is still adequate for the BF parameters , but the parameters of MTT would not be reliable .", "label": "", "metadata": {}, "score": "59.075638"}
{"text": "[ Google Scholar ] .Pandharipande , P.V. ; Krinsky , G.A. ; Rusinek , H. ; Lee , V.S. Perfusion imaging of the liver : Current challenges and future goals .", "label": "", "metadata": {}, "score": "59.25585"}
{"text": "Those patients were treated because they were on the waiting list for liver transplantation and they could undergo salvage liver transplantation in case of liver failure .", "label": "", "metadata": {}, "score": "59.265594"}
{"text": "Adverse events and toxicities will be monitored for six months following the last treatment procedure .Patients will be asked to fill out questionnaires for quality of life assessment before treatment and at 1 , 3 , 6 and 12 months after first treatment .", "label": "", "metadata": {}, "score": "59.312744"}
{"text": "PubMed Central PubMed View Article .Hepatology 2011 , 53 : 1580 - 1589 .PubMed View Article .Lencioni R , Llovet JM : Modified RECIST ( mRECIST ) assessment for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "59.32412"}
{"text": "Like for some of these studies , our results confirm that downstaging advanced HCC with PVTT is not an unrealistic objective .Indeed , allowing to 22 % ( 4/18 ) of these patients a downstaging to a curative surgical stage is a very encouraging data in the context of the classical poor outcome of this disease .", "label": "", "metadata": {}, "score": "59.33091"}
{"text": "PubMed View Article .Hepatology 2008 , 47 : 71 - 81 .PubMed View Article .Pentecost MJ , Daniels JR , Teitelbaum GP , Stanley P : Hepatic chemoembolization : safety with portal vein thrombosis .", "label": "", "metadata": {}, "score": "59.359253"}
{"text": "Chemoembolization was performed at the common hepatic artery for multiple lesions involving both lobes of liver .The total volume of emulsion was judged by the tumor size and achievement of stagnant arterial flow .", "label": "", "metadata": {}, "score": "59.407097"}
{"text": "The response was considered complete ( CR ) when a dense homogeneous Lipiodol uptake with complete disappearance of any intratumoral enhancement was observed in the target lesion at CT scan or when no enhancement of the target nodule was observed at Dynamic MRI [ 14 ] .", "label": "", "metadata": {}, "score": "59.42337"}
{"text": "View Article .Elschot M , Vermolen BJ , Lam MG , de Keizer B , van den Bosch MA , de Jong HW : Quantitative comparison of PET and bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization .", "label": "", "metadata": {}, "score": "59.446335"}
{"text": "( d )A 76-year - old woman with hepatocellular carcinoma and tumor thrombus in the main portal vein .Figure 6 : Kaplan - Meier plot showing overall survival stratified by Morphology , Attenuation , Size , and Structure ( MASS ) criteria ( FR , favorable response ; UR , unfavorable response ) .", "label": "", "metadata": {}, "score": "59.476967"}
{"text": "PubMed View Article .Lencioni R , Llovet JM : Modified RECIST ( mRECIST ) assessment for hepatocellular carcinoma .Semin Liver Dis 2010 , 30 : 52 - 60 .", "label": "", "metadata": {}, "score": "59.493828"}
{"text": "The operators avoided areas of necrosis in the tumor and kept a distance from the margins of the tumor nodule to avoid partial volume effects .", "label": "", "metadata": {}, "score": "59.535904"}
{"text": "[PubMed ] [ DOI ] .Lin WY , Wang SJ , Yeh SH .Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "59.5577"}
{"text": "However , liver perfusion is more complicated than perfusion on other organs because the liver has dual - vessel flows [ 15 ] .Several recent studies have used more dedicated dual input ( arterial / portal vein ) CT perfusion to calculate the BF of HCC [ 16 - 23 ] .", "label": "", "metadata": {}, "score": "59.706146"}
{"text": "Acad .Radiol 2008 , 15 , 919 - 927 .[ Google Scholar ] .Chen , G. ; Ma , D.Q. ; He , W. ; Zhang , B.F. ; Zhao , L.Q. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "59.860146"}
{"text": "The safety profile appears to be similar to that observed in patients without PVTT , especially for the embolic risk .This is also the case for resin microspheres : a recent series had no cases of postembolization syndrome or of hepatic ischemia [ 13 ] .", "label": "", "metadata": {}, "score": "59.86589"}
{"text": "The investigation of CT perfusion parameters of HCC could be more complicated in individuals .Thus , we further examined the HCC - parenchyma ratio of four CT perfusion parameters ( total BF , arterial BF , portal BF , arterial fraction ) , which were calculated as the data of HCC divided by that of the surrounding liver parenchyma .", "label": "", "metadata": {}, "score": "59.90696"}
{"text": "Hepatic tumor burden debulking appears to improve survival as well [ 28 - 32 ] .5-year survival rates for mNET are 50 - 59 % according to national cancer registries [ 33 , 34 ] .", "label": "", "metadata": {}, "score": "59.97337"}
{"text": "90 Y PET / CT thus presents a new opportunity to study the radiobiology of 90 Y resin microspheres in a rapid , convenient , and noninvasive manner , with the ability to tomographically evaluate the dose distribution of an entire target organ in high resolution by a single scan .", "label": "", "metadata": {}, "score": "60.086185"}
{"text": "If required , these arteries will be embolized using coils , taking the planned catheter position for injecting the microspheres into account .Additionally , 150 MBq Technetium-99 m - labeled macro aggregated albumin ( 99 m Tc - MAA ) will be injected .", "label": "", "metadata": {}, "score": "60.224262"}
{"text": "Cost - effectiveness of 90 Y - RE versus TACE will be assessed .Sample size calculation .A total of 140 patients will be included .", "label": "", "metadata": {}, "score": "60.297287"}
{"text": "Figure 1 Images obtained in a patient with HCC verified with treatment response of PR .Figure 2 Images obtained from a patient with HCC with treatment respo - nse of PD group .", "label": "", "metadata": {}, "score": "60.350414"}
{"text": "This obtains the mean VOI radioconcentration , from which the VOI - specific mean absorbed doses were approximated by MIRD formularism .dose - response analysis was strictly limited to observations within these VOIs .", "label": "", "metadata": {}, "score": "60.375244"}
{"text": "Can these treatment modalities be combined or applied sequentially ?Lastly , how do we accurately assess the clinical efficacy ?The antitumor activity of targeted agents , such as sorafenib or sunitinib , and the local treatment modalities , such as chemoembolization or radioembolization , may result in changes in tumor vascularization , cavitation , and necrosis that do not significantly affect tumor size .", "label": "", "metadata": {}, "score": "60.39243"}
{"text": "Quantification of non - target absorbed doses by 90 Y PET effectively translates subjective , qualitative information into objective and radiobiologically meaningful data to guide post - radioembolization care .", "label": "", "metadata": {}, "score": "60.398872"}
{"text": "Furthermore , non - target activity may also be present .In such situations , the prognosis remains uncertain unless retrospective dose quantification is performed within appropriate regions of interest .", "label": "", "metadata": {}, "score": "60.40132"}
{"text": "Marelli L , Stigliano R , Triantos C , Senzolo M , Cholongitas E , Davies N , Tibballs J , Meyer T , Patch DW , Burroughs AK : Transarterial therapy for hepatocellular carcinoma : which technique is more effective ?", "label": "", "metadata": {}, "score": "60.465508"}
{"text": "The diagnostic sensitivity and specificity of circulating angiogenic factors for HCC were assessed by receiver - operating characteristic ( ROC ) curves and the area under the ROC curve ( AUR ) .", "label": "", "metadata": {}, "score": "60.467373"}
{"text": "Dosimetric studies have shown 99 m Tc MAA to be feasible for simulating the post - radioembolization biodistribution of 90 Y resin microspheres [ 13 - 16 ] .", "label": "", "metadata": {}, "score": "60.475414"}
{"text": "Four of these seven patients died because of the progression of the previously treated disease . between controlled and noncontrolled patients in term of median tumor absorbed dose ( Table 2 ) .", "label": "", "metadata": {}, "score": "60.52504"}
{"text": "Intervals with durations of 12 s were taken between the 15th-16th and 18th-19th scans ( Figure 6 ) .Patients were asked to hold the breath during the CT scanning .", "label": "", "metadata": {}, "score": "60.587143"}
{"text": "One possible reason might be immature microvessels during tumor angiogenesis , and measured on histology MVD , usually present as very small tumor vessels , which would not reflect the total BF measured by CT perfusion imaging [ 6 ] .", "label": "", "metadata": {}, "score": "60.608295"}
{"text": "The mean chemotherapeutic agent dose administered per treatment was approximately 40 mg of epirubicin ( range , 20 - 75 mg ) and the mean Lipiodol dose administered was approximately 8 mL ( range , 4 - 15 mL ) .", "label": "", "metadata": {}, "score": "60.636753"}
{"text": "J Hepatol 2012 , 56 : 1330 - 1335 .PubMed View Article .Chung JW , Park JH , Han JK , Choi BI , Han MC , Lee HS , Kim CY : Hepatic tumors : predisposing factors for complications of transcatheter oily chemoembolization .", "label": "", "metadata": {}, "score": "60.665173"}
{"text": "A third TACE at four months after initial treatment will only be performed in the case of residual enhancement on the three months follow - up contrast - enhanced MRI scan of the liver .", "label": "", "metadata": {}, "score": "60.76648"}
{"text": "10.2967/jnumed.113.122846 .Kao YH , Tan EH , Ng CE , Goh SW : Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres : a technical review .", "label": "", "metadata": {}, "score": "60.797646"}
{"text": "Bruix J , Llovet JM : Major achievements in hepatocellular carcinoma .Lancet 2009 , 373 : 614 - 616 .PubMed View Article .Breedis C , Young G : The blood supply of neoplasms in the liver .", "label": "", "metadata": {}, "score": "60.92927"}
{"text": "PubMed View Article .Llovet JM , Bruix J : Systematic review of randomized trials for unresectable hepatocellular carcinoma : Chemoembolization improves survival .Hepatology 2003 , 37 : 429 - 442 .", "label": "", "metadata": {}, "score": "60.932755"}
{"text": "PubMed View Article .Llovet JM , Bruix J : Systematic review of randomized trials for unresectable hepatocellular carcinoma : Chemoembolization improves survival .Hepatology 2003 , 37 : 429 - 442 .", "label": "", "metadata": {}, "score": "60.932755"}
{"text": "Digital subtraction angiography was done with fluoroscopy to provide a map of the vascular anatomy , and vessels supplying extrahepatic structures such as the stomach or intestine were coil - embolized .", "label": "", "metadata": {}, "score": "60.94123"}
{"text": "We describe the potential of 90 Y DVHs to guide predictive dosimetry and discuss how the quantification of non - target absorbed doses may impact post - radioembolization care .", "label": "", "metadata": {}, "score": "60.988037"}
{"text": "Discussion .The therapeutic landscape has significantly evolved over the past decade largely because of a better understanding of tumor biology leading to the introduction of targeted therapies as well as technologies that revolutionized local - regional treatments .", "label": "", "metadata": {}, "score": "61.05507"}
{"text": "10.1088/0031 - 9155/53/22/019 View Article .Campbell JM , Wong CO , Muzik O , Marples B , Joiner M , Burmeister J : Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient - specific method using single photon emission computed tomography and positron emission tomography .", "label": "", "metadata": {}, "score": "61.105064"}
{"text": "212 - 220 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .Z. Sun , G. Li , X. Ai et al . , \" Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors : incidence , diagnosis , treatment , outcome and mechanism , \" Critical Reviews in Oncology / Hematology , vol . 79 , no . 2 , pp .", "label": "", "metadata": {}, "score": "61.284454"}
{"text": "[ Google Scholar ] .Ippolito , D. ; Capraro , C. ; Casiraghi , A. ; Cestari , C. ; Sironi , S. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma : Role of dynamic - CT perfusion imaging .", "label": "", "metadata": {}, "score": "61.37925"}
{"text": "According to the BCLC staging classification and treatment schedule , TACE can be considered the current standard treatment for patients with intermediate stage HCC with compensated liver disease , with a reported median survival of around 17 months [ 8 - 10 ] .", "label": "", "metadata": {}, "score": "61.451927"}
{"text": "PubMed View Article .Gastroenterology 2011 , 140 : 497 - 507 .PubMed View Article .Bruix J , Sherman M : Management of hepatocellular carcinoma : an update .", "label": "", "metadata": {}, "score": "61.50921"}
{"text": "The efficacy of these selective internal radiation treatments has not been assessed in prospective comparative trials ( versus TACE , for instance ) , but generally is considered comparable , with better tolerance for radioembolization [ 28 ] .", "label": "", "metadata": {}, "score": "61.59754"}
{"text": "[ Google Scholar ] .Kan , Z. ; Phongkitkarun , S. ; Kobayashi , S. ; Tang , Y. ; Ellis , L.M. ; Lee , T.Y. ; Charnsangavej , C. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model .", "label": "", "metadata": {}, "score": "61.652424"}
{"text": "PubMed View Article .Bruix J , Sherman M : Management of hepatocellular carcinoma .Hepatology 2005 , 42 : 1208 - 1236 .PubMed View Article .", "label": "", "metadata": {}, "score": "61.694603"}
{"text": "We avoided using tumor VOIs generated by PET volumetric isocontour thresholding as these often do not represent their true anatomical extent due to heterogeneous microsphere biodistribution .", "label": "", "metadata": {}, "score": "61.696228"}
{"text": "Recently , 70 % partial remissions with estimated overall survival of 92 % at 2 years have been reported with a temozolamide / capecitabine regimen in metastatic NET of the pancreas [ 11 ] .", "label": "", "metadata": {}, "score": "61.717514"}
{"text": "Citation : Chen G , Ma DQ , He W , Zhang BF , Zhao LQ .Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "61.786274"}
{"text": "For the kidney , we observed that a combined bilateral mean dose of 9 Gy ( V 20 8 % ) did not result in any clinically relevant nephrotoxicity .", "label": "", "metadata": {}, "score": "61.8059"}
{"text": "Overall survival was defined as the time interval between TACE and death or the date of the last follow - up .Univariate analysis was carried out in order to identify the factors predicting survival .", "label": "", "metadata": {}, "score": "61.931038"}
{"text": "15 , Supplement , abstract 4580 , 2011 .View at Google Scholar .J. L. Raoul , E. Boucher , Y. Rolland , and E. Garin , \" Treatment of hepatocellular carcinoma with intra - arterial injection of radionuclides , \" Nature Reviews Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "61.94333"}
{"text": "The main underlying etiology was alcohol ( . )All tumors were unilobular with 7 showing multifocal and 3 infiltrating patterns .The PVTT was ipsilateral in all cases , branch thrombosis in 10 , and intrahepatic trunk thrombosis in 8 , extending to lobular or segmental branches in 3 patients and to a hepatic vein in one .", "label": "", "metadata": {}, "score": "61.96277"}
{"text": "10.1097/MNM.0b013e3283524220 View Article .Dieudonn\u00e9 A , Garin E , Laffont S , Rolland Y , Lebtahi R , Leguludec D , Gardin I : Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90 Y - microspheres .", "label": "", "metadata": {}, "score": "61.97163"}
{"text": "Conclusions .Transarterial chemoembolization is a valid treatment option in patients with single HCC not suitable for curative treatment .Bland PVT has no major impact on survival and a slight impairment of PS attributable to cirrhosis in patients within the Milan criteria should not preclude the use of TACE .", "label": "", "metadata": {}, "score": "61.992435"}
{"text": "41 - 49 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Salem , R. J. Lewandowski , L. Kulik et al . , \" Radioembolization results in longer time - to - progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "62.1098"}
{"text": "PubMed View Article .Abdom Imaging 2008 , 33 : 512 - 519 .PubMed View Article .Poon RT , Tso WK , Pang RW , Ng KK , Woo R , Tai KS , Fan ST : A phase I / II trial of chemoembolization for hepatocellular carcinoma using a novel intra - arterial drug - eluting bead .", "label": "", "metadata": {}, "score": "62.162876"}
{"text": "Readers who are accustomed to semi - empirical therapy planning may struggle to understand the dosimetric concepts discussed in this paper or its relevance to clinical practice .", "label": "", "metadata": {}, "score": "62.29915"}
{"text": "1205 - 1212 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .L. M. Kulik , B. I. Carr , M. F. Mulcahy et al . , \" Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "62.312397"}
{"text": "Imaging 2006 , 31 , 188 - 193 .[ Google Scholar ] .Hanahan , D. ; Folkman , J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis .", "label": "", "metadata": {}, "score": "62.34313"}
{"text": "In principle , 90 Y radioembolization planned by predictive dosimetry is not subject to prognostic uncertainties experienced by semi - empirical 90 Y activity prescription , a common practice within the medical oncology paradigm .", "label": "", "metadata": {}, "score": "62.378212"}
{"text": "View Article .Carlier T , Eug\u00e8ne T , Bodet - Milin C , Garin E , Ansquer C , Rousseau C , Ferrer L , Barbet J , Schoenahl F , Kraeber - Bod\u00e9r\u00e9 F : Assessment of acquisition protocols for routine imaging of Y-90 using PET / CT .", "label": "", "metadata": {}, "score": "62.403275"}
{"text": "PubMed View Article .Raoul JL , Sangro B , Forner A , Mazzaferro V , Piscaglia F , Bolondi L , Lencioni R : Evolving strategies for the management of intermediate - stage hepatocellular carcinoma : available evidence and expert opinion on the use of transarterial chemoembolization .", "label": "", "metadata": {}, "score": "62.431244"}
{"text": "Methods .Retrospective dose quantification of 90 Y resin microspheres was performed on the same 23-patient data set in part 1 .Phantom studies were performed to assure quantitative accuracy of our time - of - flight lutetium - yttrium - oxyorthosilicate system .", "label": "", "metadata": {}, "score": "62.43668"}
{"text": "Transarterial chemoembolization .Transarterial chemoembolization ( TACE ) is a procedure in which a catheter is advanced into the branches of the hepatic artery supplying the tumor , and a combination of embolic material and chemotherapeutics is delivered through the catheter directly into the tumor .", "label": "", "metadata": {}, "score": "62.44838"}
{"text": "Eur Radiol 2009 , 19 : 951 - 959 .PubMed View Article .Gastroenterology 2010 , 138 : 52 - 64 .PubMed View Article .", "label": "", "metadata": {}, "score": "62.520107"}
{"text": "Patients submitted to liver transplant ( LT ) were excluded from the analysis ( 34 patients ) .The assessment of tumor response was considered at 1 month after TACE .", "label": "", "metadata": {}, "score": "62.531235"}
{"text": "[ Google Scholar ] .Kornacker , M. ; Roth , A. ; Christensen , O. ; Kratzschmar , J. ; Wensing , G. Quantification of vascular endothelial growth factor , interleukin-8 , and basic fibroblast growth factor in plasma of cancer patients and healthy volunteers - Comparison of ELISA and microsphere - based multiplexed immunoassay .", "label": "", "metadata": {}, "score": "62.603867"}
{"text": "[PubMed ] [ DOI ] .Nakamura H , Hashimoto T , Oi H , Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma .Radiology .", "label": "", "metadata": {}, "score": "62.631668"}
{"text": "Non - target 90 Y activity along the gastric greater curve causing CTCAE grade 3 toxicity [ 1 ] .A 90 Y PET VOI of the activity along the gastric greater curve was defined by volumetric isocontour thresholding , visually constrained to its CT anatomical margins , shown here in ( a ) trans - axial , ( b ) coronal , and ( c ) sagittal planes .", "label": "", "metadata": {}, "score": "62.68782"}
{"text": "Overall patient survival after TACE .Out of the 148 patients who underwent TACE , 79 ( 53 % ) died within the study period ( January 2004 - May 2012 ) and 4 patients were lost to follow - up .", "label": "", "metadata": {}, "score": "62.693592"}
{"text": "This was caused , in part , by technical limitations imposed by the overlying anatomy [ 12 , 13 ] .In selective internal radiotherapy ( SIRT ) with yttrium-90 microspheres , radioactive particles are injected into the hepatic artery , become trapped at the precapillary level , and emit lethal radiation to the tumor [ 6 , 14 , 15 ] .", "label": "", "metadata": {}, "score": "62.893497"}
{"text": "449 - 455 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Bruix and M. Sherman , \" Management of hepatocellular carcinoma , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "62.923706"}
{"text": "Patients assigned to TACE will receive a maximum of three consecutive transarterial treatment sessions .Patients will undergo structural follow - up for a timeframe of two years post treatment .", "label": "", "metadata": {}, "score": "62.944427"}
{"text": "Celiac artery stenting of the stenosis was performed to facilitate subsequent safe and successfulYttrium-90 microsphere radioembolization .all Addendum Article Book Review Case Report Comment Commentary Communication Concept Paper Conference Report Correction Creative Data Descriptor Discussion Editorial Erratum Essay Interesting Images Letter New Book Received Obituary Opinion Project Report Reply Retraction Review Short Note Technical Note .", "label": "", "metadata": {}, "score": "63.064533"}
{"text": "Differences in quality of life ( as measured by standard questionnaires ) over time between the two arms will be analyzed by means of Linear Mixed Model analysis .", "label": "", "metadata": {}, "score": "63.071697"}
{"text": "497 - 507 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. M. Ibrahim , R. J. Lewandowski , K. T. Sato et al . , \" Radioembolization for the treatment of unresectable hepatocellular carcinoma : a clinical review , \" World Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "63.07977"}
{"text": "10.1186/2191 - 219X-3 - 11 View Article .Walrand S , Jamar F , van Elmbt L , Lhommel R , Bekonde EB , Pauwels S : 4-Step renal dosimetry dependent on cortex geometry applied to 90 Y peptide receptor radiotherapy : evaluation using a fillable kidney phantom imaged by 90 Y PET .", "label": "", "metadata": {}, "score": "63.096123"}
{"text": "62 - 67 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Sorrentino , L. Tarantino , S. D'Angelo et al . , \" Validation of an extension of the international non - invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis , \" Journal of Gastroenterology and Hepatology , vol .", "label": "", "metadata": {}, "score": "63.10121"}
{"text": "397 - 400 , 1998 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Llovet , C. Br\u00fa , and J. Bruix , \" Prognosis of hepatocellular carcinoma : the BCLC staging classification , \" Seminars in Liver Disease , vol .", "label": "", "metadata": {}, "score": "63.10893"}
{"text": "Buijs M , Vossen JA , Frangakis C , Hong K , Georgiades CS , Chen Y , Liapi E , Geschwind JF : Nonresectable hepatocellular carcinoma : long - term toxicity in patients treated with transarterial chemoembolization - single - center experience .", "label": "", "metadata": {}, "score": "63.180332"}
{"text": "PubMed View Article .Burrel M , Reig M , Forner A , Barrufet M , de Lope CR , Tremosini S , Ayuso C , Llovet JM , Real MI , Bruix J : Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation ( TACE ) using Drug Eluting Beads .", "label": "", "metadata": {}, "score": "63.194855"}
{"text": "J. Roentgenol 2004 , 183 , 713 - 719 .[ Google Scholar ] .Hafstrom , L. ; Nobin , A. ; Persson , B. ; Sundqvist , K. Effects of catecholamines on cardiovascular response and blood flow distribution to normal tissue and liver tumors in rats .", "label": "", "metadata": {}, "score": "63.28432"}
{"text": "Trial status .The trial is currently including patients .The first 10 patients have been minimized and treated according to the allocated treatment arm .", "label": "", "metadata": {}, "score": "63.326775"}
{"text": "The PRECISION V trial compared conventional TACE with TACE - DEB in a large , randomized study [ 22 ] .Subgroup analysis showed that TACE - DEB results in a higher tumor control rate in patients with Child - Pugh B cirrhosis , bilobar disease or reduced performance score compared to conventional TACE .", "label": "", "metadata": {}, "score": "63.35293"}
{"text": "( a )Before selective internal radiotherapy ( SIRT ) , tumor diameter was 8.4 cm .In the present study we attempted to objectively quantify the radiographic tumor features on CT scans prior to treatment with SIRT .", "label": "", "metadata": {}, "score": "63.375366"}
{"text": "A phase II trial of Yttrium-90 resin microspheres in combination with systemic FU chemotherapy was conducted with 34 patients .While this represented first - line therapy for the majority of patients , 29 % had failed prior liver resection and 15 % had received earlier chemotherapy , with 59 % also manifesting extrahepatic disease .", "label": "", "metadata": {}, "score": "63.379845"}
{"text": "Continued research into predictive dosimetry promises abundant rewards for safer and more effective 90 Y radioembolization , especially as it expands into organs other than the liver .", "label": "", "metadata": {}, "score": "63.43303"}
{"text": "Abbreviations : CPT Child - Pugh - Turcotte score , INR international normalized ratio .Discussion .Curative treatment is recommended as the first - line treatment for patients with single HCC regardless of tumor diameter [ 1 , 7 ] .", "label": "", "metadata": {}, "score": "63.435265"}
{"text": "The size of the ROI remained constant in different measurements and in different patients .To compare the relative difference of vascularity between HCC and surrounding liver parenchyma , we measured the average CT perfusion parameters of HCC relative to background non - tumor liver parenchyma and calculated the ratio of BF parameters between the HCC and liver parenchyma ( HCC - parenchyma ratio ) .", "label": "", "metadata": {}, "score": "63.452583"}
{"text": "Screen display of a target HCC on MIstar workstation with full functional images and enhancing curve of HCC and liver parenchyma .CT functional maps include arterial BF ( upper left ) , portal BF ( upper middle ) , total BF ( upper right ) , and arterial fraction ( lower left ) .", "label": "", "metadata": {}, "score": "63.5692"}
{"text": "Screen display of a target HCC on MIstar workstation with full functional images and enhancing curve of HCC and liver parenchyma .CT functional maps include arterial BF ( upper left ) , portal BF ( upper middle ) , total BF ( upper right ) , and arterial fraction ( lower left ) .", "label": "", "metadata": {}, "score": "63.5692"}
{"text": "PubMed View Article .Liver Transpl 2007 , 13 : 857 - 866 .PubMed View Article .Takayasu K , Arii S , Kudo M , Ichida T , Matsui O , Izumi N , Matsuyama Y , Sakamoto M , Nakashima O , Ku Y , Kokudo N , Makuuchi M : Superselective transarterial chemoembolization for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "63.57863"}
{"text": "However , accurate tissue radiation thresholds for 90 Y resin microspheres have remained elusive despite more than two decades of clinical use .As a consequence of this uncertainty , dosimetric dilemmas may be encountered in patients who may benefit from radiation planning up to the limits of normal tissue radiation tolerance .", "label": "", "metadata": {}, "score": "63.602898"}
{"text": "1377 - 1384 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. E. Woodall , C. R. Scoggins , S. F. Ellis et al . , \" Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis ? \"", "label": "", "metadata": {}, "score": "63.61271"}
{"text": "Ippolito , D. ; Bonaffini , P.A. ; Ratti , L. ; Antolini , L. ; Corso , R. ; Fazio , F. ; Sironi , S. Hepatocellular carcinoma treated with transarterial chemoembolization : Dynamic perfusion - CT in the assessment of residual tumor .", "label": "", "metadata": {}, "score": "63.66378"}
{"text": "In case a lung dose exceeding 30 Gy ( 610 MBq ) in a single treatment ( or 50 Gy cumulatively in case of repeated treatment ) is predicted , an activity reduction will be prescribed [ 32 ] .", "label": "", "metadata": {}, "score": "63.66667"}
{"text": "Four patients were downstaged .Treating lobar hepatocellular carcinoma with ipsilateral portal vein thrombosis with yttrium-90 glass - microsphere radioembolization is safe and efficacious .Further clinical trials are warranted to confirm these results and to compare 90 Y - microS with sorafenib , taking into account not only survival but also the possibility of secondary surgery for putative curative intention after downstaging .", "label": "", "metadata": {}, "score": "63.75489"}
{"text": "In this pragmatic randomized controlled trial , 140 patients with unresectable ( BCLC intermediate stage ) hepatocellular carcinoma , with Eastern Cooperative Oncology Group performance status 0 to 1 and Child - Pugh A to B will be randomly assigned to either 90 Y - RE or TACE with drug eluting beads .", "label": "", "metadata": {}, "score": "63.772583"}
{"text": "Vials of microspheres were obtained by convenience sampling , either before or after extraction of the desired treatment activity .The vials were placed within a perspex body phantom and scanned in one bed position over 15 min ( Figure 1 ) .", "label": "", "metadata": {}, "score": "63.78012"}
{"text": "Several prospective and retrospective studies demonstrated the safety and efficacy of 90Y - RE treatment for unresectable HCC , all documented in a recent review [ 23 ] .", "label": "", "metadata": {}, "score": "63.888527"}
{"text": "Circulating Angiogenic Factors and CT Perfusion Parameters .After statistical analysis , none of the circulating angiogenesis factors were significantly correlated with any of the CT perfusion parameters , such as total BF , arterial BF , portal BF , and arterial fraction ( Table 2 ) .", "label": "", "metadata": {}, "score": "63.907047"}
{"text": "This resulted in different enhancement and body habitus in individual patients , and led to different measurements of attenuation of the X - ray beam and different Houndsfield unit values .", "label": "", "metadata": {}, "score": "63.939495"}
{"text": "Cure can only be achieved by hepatic resection , liver transplantation and in certain cases by radiofrequency ablation ( RFA ) [ 3 ] .Although there is no universally accepted HCC staging system , many have adopted the Barcelona Clinic Liver Cancer ( BCLC ) staging classification , which links the stage of the disease to a specific treatment strategy [ 4 , 5 ] .", "label": "", "metadata": {}, "score": "63.963966"}
{"text": "In general , former wait - andsee strategies even in well - differentiated tumors with minor - to - moderate tumor loads will have to be reevaluated , as tumor progression , with median TTP of 6 months , is inevitable [ 5 ] .", "label": "", "metadata": {}, "score": "63.98005"}
{"text": "[PubMed ] [ DOI ] .Tsushima Y , Unno Y , Koizumi J , Kusano S. Hepatic perfusion changes after transcatheter arterial embolization ( TAE ) of hepatocellular carcinoma : measurement by dynamic computed tomography ( CT ) .", "label": "", "metadata": {}, "score": "64.001625"}
{"text": "Excess radiation exposure of CT perfusion limited the recruitment of more patients in our study and future clinical applications .However , our study has shown that the circulating IL-8 could be a feasible and noninvasive tool to examine BF in HCC to avoid ionizing radiation .", "label": "", "metadata": {}, "score": "64.018745"}
{"text": "10.1118/1.2889621 View Article .Boucek JA , Kao YH , Francis RJ :Yttrium-90 PET / CT voxel dosimetry .Western Australia , Australia : Department of Nuclear Medicine , Sir Charles Gairdner Hospital ; 2012 .", "label": "", "metadata": {}, "score": "64.03077"}
{"text": "4 , pp .537 - 543 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . R. Murthy , P. Kamat , R. Nunez et al . , \" Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "64.07207"}
{"text": "No dose adjustment will be made for bilirubin concentration or body surface area .Dose determination is based on previous dose escalation studies , in which DEBs loaded with doxorubicin up to 150 mg were shown to be safe and effective [ 19 , 20 ] , and recommendations from the literature [ 17 , 22 ] .", "label": "", "metadata": {}, "score": "64.10129"}
{"text": "A trend towards higher pre - TACE values of alpha - fetoprotein ( AFP ) was found in incomplete responders .Table 3 .Clinical and tumor characteristics of the whole patient cohort before TACE treatment according to tumor response .", "label": "", "metadata": {}, "score": "64.12248"}
{"text": "Patients were staged by Child - Pugh score , United Network for Organ Sharing ( UNOS ) score , and Barcelona Clinic Liver Cancer ( BCLC ) score ( A , early ; B , intermediate ; C , advanced ; D , end - stage ) [ 17 , 18 ] .", "label": "", "metadata": {}, "score": "64.216415"}
{"text": "Two of them had complete involution of their PVTT ( Figure 1 ) .The two patients who received an intensified treatment showed a partial response without any significant toxicity .", "label": "", "metadata": {}, "score": "64.21856"}
{"text": "J. Med 1971 , 285 , 1182 - 1186 .[ Google Scholar ] .Asayama , Y. ; Yoshimitsu , K. ; Nishihara , Y. ; Irie , H. ; Aishima , S. ; Taketomi , A. ; Honda , H. Arterial blood supply of hepatocellular carcinoma and histologic grading : Radiologic - pathologic correlation .", "label": "", "metadata": {}, "score": "64.21886"}
{"text": "Tumor 90 Y DVH dose - response results involving hepatocellular carcinomas ( HCC ) , cholangiocarcinoma , and adrenal metastatic gastrointestinal stromal tumor ( GIST ; Figures 3 and 4 ) are presented in Table 1 . dose - response results of portal vein tumor thrombosis by 90 Y MIRD macrodosimetry ( Figure 6 ) are presented in Table 2 .", "label": "", "metadata": {}, "score": "64.311386"}
{"text": "J Vasc Interv Radiol 2011 , 22 : 265 - 278 .10.1016/j.jvir.2010.10.029 View Article .Kao YH : Results confounded by a disregard for basic dose - response radiobiology .", "label": "", "metadata": {}, "score": "64.358505"}
{"text": "Chem .Lab .Med 2008 , 46 , 1256 - 1264 .[ Google Scholar ] .Hsu , C.-Y. ; Shen , Y.-C. ; Yu , C.-W. ; Hsu , C. ; Hu , F.-C. ; Hsu , C.-H. ; Chen , B.-B. ; Wei , S.-Y. ; Cheng , A.-L. ; Shih , T.T.-F. Dynamic contrast - enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur / uracil .", "label": "", "metadata": {}, "score": "64.42807"}
{"text": "The minimization procedure will be stratified by treatment center , with the aid of validated software , whereby a random component ( 10 % ) is to be introduced .", "label": "", "metadata": {}, "score": "64.44838"}
{"text": "Hamoui N , Gates VL , Gonzalez J , Lewandowski RJ , Salem R : Radioembolization of renal cell carcinoma using yttrium-90 microspheres .J Vasc Interv Radiol 2013 , 24 : 298 - 300 .", "label": "", "metadata": {}, "score": "64.45158"}
{"text": "A total of 15 phantom scans were performed .Detector saturation was not a problem without 90 Y bremsstrahlung shielding .Detector linearity .Linear regression line ( dotted ) of total vial sediment activities quantified by 90 Y PET versus that of a dose calibrator .", "label": "", "metadata": {}, "score": "64.47136"}
{"text": "This tumor was rated as progressive disease by RECIST 1.1 but favorable response by MASS criteria .Figure 2 : A 61-year - old woman with cirrhosis with multifocal hepatocellular carcinoma in liver segments II and III .", "label": "", "metadata": {}, "score": "64.5206"}
{"text": "[ Google Scholar ] .Yeh , C.N. ; Lee , W.C. ; Jeng , L.B. ; Chen , M.F. Hepatic resection for hepatocellular carcinoma in Taiwan .", "label": "", "metadata": {}, "score": "64.54885"}
{"text": "To date , no prospective studies have been performed comparing both treatment modalities in a randomized setting .This randomized controlled trial is designed to prospectively compare TACE and 90 Y - RE for treatment of patients with unresectable ( BCLC intermediate stage ) HCC .", "label": "", "metadata": {}, "score": "64.56556"}
{"text": "Patient population .The present retrospective analysis was based on a database of 902 consecutive patients who underwent TACE as a first line treatment between January 2004 and December 2009 in the Interventional Radiology Unit of Sant'Orsola - Malpighi Hospital in Bologna after a multidisciplinary team ( MDT ) discussion .", "label": "", "metadata": {}, "score": "64.591156"}
{"text": "Conversely , the MASS criteria , which include additional radiologic tumor parameters such as morphology , necrosis , attenuation , and structure , were significantly associated with progression - free and overall survival .", "label": "", "metadata": {}, "score": "64.62915"}
{"text": "A dynamic study of the selected area was performed in a single breath hold at a static supine position .A total of 40 - 50 mL of non - ion iodinated contrast medium ( Iohexol300 , 300 mg of iodine per milliliter ) was injected at a rate of 4 mL / s through an 18-gauge intravenous cannula .", "label": "", "metadata": {}, "score": "64.63316"}
{"text": "By 90 Y MIRD macrodosimetry , the mean absorbed dose of the portal vein tumor thrombus was approximately 316 Gy within the VOI .( d ) Follow - up triphasic CT of the liver in the arterial phase at 4 months post - radioembolization demonstrates a complete lack of contrast enhancement within the VOI ( arrow ) , suggesting a complete response and clinically validates the 90 Y PET quantification .", "label": "", "metadata": {}, "score": "64.63552"}
{"text": "HCC vascular functional maps of total BF , arterial BF , portal BF , and arterial fraction were generated on a workstation ( Figure 7 ) .", "label": "", "metadata": {}, "score": "64.69343"}
{"text": "4656 - 4663 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .C. Waldherr , M. Pless , H. R. Maecke et al . , \" Tumor response and clinical benefit in neuroendocrine tumors after 7.4 Gbq 90Y - DOTATOC , \" Journal of Nuclear Medicine , vol .", "label": "", "metadata": {}, "score": "64.72469"}
{"text": "Cases of non - target activity were followed up by retrospective review of clinical records , and relevant clinical toxicities were graded according to the Common Terminology Criteria for Adverse Events version 4.03 ( CTCAE ; National Institutes of Health , Bethesda , MD , USA ) .", "label": "", "metadata": {}, "score": "64.77985"}
{"text": "10.1007/s00259 - 012 - 2189 - 6 View Article .Ho S , Lau WY , Leung TW , Chan M , Ngar YK , Johnson PJ , Li AK : Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours .", "label": "", "metadata": {}, "score": "64.78047"}
{"text": "Intended tumor mean doses by 99 m Tc MAA SPECT / CT predictive dosimetry correlated well with post - radioembolization doses by 90 Y PET .", "label": "", "metadata": {}, "score": "64.808365"}
{"text": "Chen G , Ma DQ , He W , Zhang BF , Zhao LQ .Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "64.89604"}
{"text": "Clinical management of hepatocellular carcinoma .Conclusions of the Barcelona-2000 EASL conference .European Association for the Study of the Liver .J Hepatol 2001 , 35 : 421 - 430 .", "label": "", "metadata": {}, "score": "64.90527"}
{"text": "292 - 300 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .J. R. Strosberg , R. L. Fine , J. Choi et al . , \" First - line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas , \" Cancer , vol .", "label": "", "metadata": {}, "score": "64.93773"}
{"text": "AST : . aspartate aminotrasferase .BCLC : .Barcelona Clinic Liver Cancer .CT : . computed tomography .CTCAE : .National Cancer Institute Common Terminology Criteria for Adverse Events .", "label": "", "metadata": {}, "score": "65.009766"}
{"text": "In case of bilobar disease , the right and left lobe will be treated in two separate sessions , with a generally accepted interval of 30 to 45 days .", "label": "", "metadata": {}, "score": "65.03204"}
{"text": "PubMed View Article .Malagari K , Pomoni M , Kelekis A , Pomoni A , Dourakis S , Spyridopoulos T , Moschouris H , Emmanouil E , Rizos S , Kelekis D : Prospective randomized comparison of chemoembolization with doxorubicin - eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "65.06569"}
{"text": "Five patients had had one or more previous treatments : TACE ( .This retrospective study was approved by the institutional ethic board .Treatment Planning .", "label": "", "metadata": {}, "score": "65.125275"}
{"text": "We only evaluated four of the most discussed circulating angiogenic factors of HCC , and other related circulating angiogenic factors were not examined .Increased circulating angiogenic factors may be released from peripheral blood , monocytes , liver fibrosis , or HCC [ 27 ] .", "label": "", "metadata": {}, "score": "65.22818"}
{"text": "Review of available data shows encouraging safety and efficacy profiles for the intraarterial application of 90Y for the treatment of mNETs of the liver .Symptom control and decrease in somatostatin analog use can be achieved , as well as prolonged survival .", "label": "", "metadata": {}, "score": "65.25011"}
{"text": "Patients were evaluated every 3 to 6 months for response , survival , and toxicity .Mean follow - up was 13.0 months ( 2.2 - 50.6 ) .", "label": "", "metadata": {}, "score": "65.267136"}
{"text": "23 , no . 8 , pp .947 - 952 , 1996 .View at Google Scholar \u00b7 View at Scopus . A. Trotti , A. D. Colevas , A. Setser et al . , \" CTCAE v3.0 : development of a comprehensive grading system for the adverse effects of cancer treatment , \" Seminars in Radiation Oncology , vol .", "label": "", "metadata": {}, "score": "65.298004"}
{"text": "Chemoembolization was performed with cisplatin , doxorubicin , and mitomycin ( Mutamycin ) emulsified with lipiodol , along with polyvinyl alcohol particles and microspheres ( Embospheres , BioSphere Medical , Rockland , Massachusetts ) .", "label": "", "metadata": {}, "score": "65.449234"}
{"text": "10.1007/s00259 - 010 - 1470 - 9 View Article .Walrand S , Lhommel R , Goffette P , Van den Eynde M , Pauwels S , Jamar F : Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy .", "label": "", "metadata": {}, "score": "65.51254"}
{"text": "A majority of patients have locally advanced , liver restricted disease ( Barcelona Clinic Liver Cancer ( BCLC ) staging system intermediate stage ) .Transarterial loco regional treatment modalities offer palliative treatment options for these patients ; transarterial chemoembolization ( TACE ) is the current standard treatment .", "label": "", "metadata": {}, "score": "65.515625"}
{"text": "The levels of circulating angiogenic factors distinguished between HCC patients and healthy controls in previous studies [ 25 - 28 , 37 ] .We also demonstrated circulating IL-6 , IL-8 , and VEGF had higher concentrations in HCC patients .", "label": "", "metadata": {}, "score": "65.52829"}
{"text": "5 , pp .1741 - 1749 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. I\u00f1arrairaegui , K. G. Thurston , J. I. Bilbao et al . , \" Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "65.55208"}
{"text": "Portal vein thrombosis was considered to be bland or neoplastic based on definite criteria previously reported by our group [ 9 ] .In the series of consecutive patients , one hundred and forty - eight patients fulfilled the inclusion criteria , and were therefore selected as the cohort for the study ( Figure 1 ) .", "label": "", "metadata": {}, "score": "65.6009"}
{"text": "251 , no .5 , pp .910 - 916 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus . A. S. Kennedy , P. McNeillie , W. A. Dezarn et al . , \" Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y - microspheres for unresectable hepatic tumors , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "65.6199"}
{"text": "Cancer Res 2007 , 13 , 777s-780s .[ Google Scholar ] .Bruix , J. ; Sherman , M. ; Llovet , J.M. ; Beaugrand , M. ; Lencioni , R. ; Burroughs , A.K. ; Christensen , E. ; Pagliaro , L. ; Colombo , M. ; Rodes , J. Clinical management of hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "65.62646"}
{"text": "J. Surg .Oncol 2002 , 28 , 652 - 656 .[ Google Scholar ] .Folkman , J. Tumor angiogenesis : Therapeutic implications .", "label": "", "metadata": {}, "score": "65.7201"}
{"text": "The median diameter of the dominant liver lesion was 9.3 cm and 8.2 cm , respectively .Some 33 % to 43 % of patients had extrahepatic disease , and the liver metastases were multilobar in 67 % to 87 % of cases .", "label": "", "metadata": {}, "score": "65.76044"}
{"text": "147 - 156 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .I. Zerizer , A. Al - Nahhas , D. Towey , et al . , \" The role of early 18 F - FDG PET / CT in prediction of progression - free survival after 90 Y radioembolization : comparison with RECIST and tumour density criteria , \" European Journal of Nuclear Medicine and Molecular Imaging , vol .", "label": "", "metadata": {}, "score": "65.764915"}
{"text": "There is no difference in TTP in patients with intermediate stage HCC treated with 90 Y - RE or TACE - DEB .The alternative hypothesis is two - sided ( 90 Y - RE could have a shorter or a longer TTP ) .", "label": "", "metadata": {}, "score": "65.771545"}
{"text": "Our interesting results do not seem influenced by the 27.7 % ( 5/18 ) of patients previously treated .Indeed , even if all these patients showed a partial response on their liver tumor , 2 only of them showed partial patency of their portal vein tumor thrombosis .", "label": "", "metadata": {}, "score": "65.78958"}
{"text": "Goedicke A , Berker Y , Verburg F , Behrendt F , Winz O , Mottaghy F : Study - parameter impact in quantitative 90-yttrium PET imaging for radioembolization treatment monitoring and dosimetry .", "label": "", "metadata": {}, "score": "65.82952"}
{"text": "By 90 Y MIRD macrodosimetry , the non - target mean absorbed dose to the gastric greater curve was approximately 49 Gy within the VOI .", "label": "", "metadata": {}, "score": "65.94464"}
{"text": "PubMed .Eur J Radiol 2012 , 81 : 1173 - 1178 .PubMed View Article .Malagari K , Chatzimichael K , Alexopoulou E , Kelekis A , Hall B , Dourakis S , Delis S , Gouliamos A , Kelekis D : Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads : results of an open - label study of 62 patients .", "label": "", "metadata": {}, "score": "65.96364"}
{"text": "T. Steinmuller , R. Kianmanesh , M. Falconi et al . , \" Consensus guidelines for the management of patients with liver metastases from digestive ( neuro)endocrine tumors : foregut , midgut , hindgut , and unknown primary , \" Neuroendocrinology , vol .", "label": "", "metadata": {}, "score": "66.03862"}
{"text": "Jpn .J. Clin .Oncol 2004 , 34 , 184 - 190 .[ Google Scholar ] .Ren , Y. ; Poon , R.T. ; Tsui , H.T. ; Chen , W.H. ; Li , Z. ; Lau , C. ; Yu , W.C. ; Fan , S.T. Interleukin-8 serum levels in patients with hepatocellular carcinoma : Correlations with clinicopathological features and prognosis .", "label": "", "metadata": {}, "score": "66.0582"}
{"text": "Before selective internal radiotherapy ( SIRT ) , the tumor ( 13.3 cm ) had central necrosis .( b )After SIRT , the tumor had minimal increase in size , increased necrosis , and decreased mean attenuation .", "label": "", "metadata": {}, "score": "66.28279"}
{"text": "Injection of DEBs will be performed as selectively as possible after Cone - Beam CT confirmed perfusion of the target lesions .If selective administration is not possible , a lobar treatment will be performed .", "label": "", "metadata": {}, "score": "66.32878"}
{"text": "[ 2 - 4 ] .HCC angiogenesis has been identified as being critical for tumor growth and metastasis [ 5 - 7 ] .Therefore , quantification of tumor angiogenesis or blood flow ( BF ) is important for risk stratification , disease progression , and response to cancer therapy [ 5 , 6 ] .", "label": "", "metadata": {}, "score": "66.40208"}
{"text": "Similarly , our data indicated the circulating IL-6 , VEGF , and IL-8 were sensitive and specific for predicting the occurrence of HCC among healthy controls and HCC patients [ 25 , 26 , 37 ] .", "label": "", "metadata": {}, "score": "66.51313"}
{"text": "Recent retrospective analyses of single - center series have demonstrated an acceptable safety profile for new modalities of selective internal radiation therapy ( SIRT ) using radiolabeled glass microspheres , even in the presence of PVTT [ 12 - 18 ] .", "label": "", "metadata": {}, "score": "66.54462"}
{"text": "[ Google Scholar ] .Zhu , A.X. ; Holalkere , N.S. ; Muzikansky , A. ; Horgan , K. ; Sahani , D.V. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "66.562454"}
{"text": "120 - 125 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. K. Cho , J. W. Chung , J. K. Kim , et al . , \" Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization , \" Cancer , vol .", "label": "", "metadata": {}, "score": "66.66113"}
{"text": "[ Google Scholar ] .Ellegala , D.B. ; Leong - Poi , H. ; Carpenter , J.E. ; Klibanov , A.L. ; Kaul , S. ; Shaffrey , M.E. ; Sklenar , J. ; Lindner , J.R. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3 .", "label": "", "metadata": {}, "score": "66.757034"}
{"text": "Example of a 90 Y PET/ CT phantom scan with maximum intensity projection image .( a ) Trans - axial , ( b ) coronal , and ( c ) sagittal planes .", "label": "", "metadata": {}, "score": "66.81166"}
{"text": "PubMed View Article .Cardiovasc Intervent Radiol 2010 , 33 : 41 - 52 .PubMed View Article .Sangro B , Salem R , Kennedy A , Coldwell D , Wasan H : Radioembolization for hepatocellular carcinoma : a review of the evidence and treatment recommendations .", "label": "", "metadata": {}, "score": "66.82033"}
{"text": "Patients underwent Child - Pugh classification for measuring acuteness of liver disease .Among those 21 patients , one of them had metastases to lung and seven patients had lymph node metastases .", "label": "", "metadata": {}, "score": "66.86859"}
{"text": "10.2967/jnumed.111.094235 View Article .Lhommel R , van Elmbt L , Goffette P , Van den Eynde M , Jamar F , Pauwels S , Walrand S : Feasibility of 90 Y TOF PET - based dosimetry in liver metastasis therapy using SIR - Spheres .", "label": "", "metadata": {}, "score": "67.07506"}
{"text": "[PubMed ] [ DOI ] .Yoshioka H , Nakagawa K , Shindou H , Ono Y , Kawakami A , Mabuchi N , Arita S , Fujii K , Hamada T , Ishida O. MR imaging of the liver before and after transcatheter hepatic chemo - embolization for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "67.07986"}
{"text": "Kan et al [ 16 ] reported that post - embolization MTT is elongated in intrahepatic lesions of a rat model , while post - embolization PS is significantly decreased .", "label": "", "metadata": {}, "score": "67.19707"}
{"text": "To date , there is no published data on the use of 90 Y PET for post - radioembolization lung dose quantification .Nevertheless , we recognize the importance of tissue radiobiology in non - tumorous liver and lungs for the safe and effective clinical application of predictive dosimetry in 90 Y radioembolization .", "label": "", "metadata": {}, "score": "67.1979"}
{"text": "4 , pp .669 - 677 , 2011 .View at Publisher \u00b7 View at Google Scholar .J. L. Raoul , D. Guyader , J. F. Bretagne et al . , \" Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis : intra - arterial iodine-131-iodized oil versus medical support , \" Journal of Nuclear Medicine , vol .", "label": "", "metadata": {}, "score": "67.2019"}
{"text": "Antitumoral agents , such as cytotoxic drugs or radionuclides , can be delivered at the site of the tumor , as they lodge in the peritumoral vascular bed after intra - arterial injection .", "label": "", "metadata": {}, "score": "67.27663"}
{"text": "PubMed View Article .Varela M , Real MI , Burrel M , Forner A , Sala M , Brunet M , Ayuso C , Castells L , Montana X , Llovet JM , Bruix J : Chemoembolization of hepatocellular carcinoma with drug eluting beads : efficacy and doxorubicin pharmacokinetics .", "label": "", "metadata": {}, "score": "67.31925"}
{"text": "This is a condition in which the patient experiences abdominal pain , fever , ileus and nausea , self - limiting hours to days after the procedure , probably due to damage of hepatocytes [ 21 ] .", "label": "", "metadata": {}, "score": "67.32402"}
{"text": "A lobar technique was carried out in the case of a nodule fed by multiple arteries or when the selective / superselective catheterization of the feeding artery was not technically feasible .", "label": "", "metadata": {}, "score": "67.343094"}
{"text": "The presence of bland PVT in patients with HCC represents a challenging therapeutic issue .In fact , more recent studies have demonstrated that TACE could be a safe treatment option for HCC patients with PV occlusion especially when performed in a selective manner [ 26 ] , and that TACE could have a survival benefit over conservative treatment [ 27 , 28 ] .", "label": "", "metadata": {}, "score": "67.48743"}
{"text": "Radiolabeled particles injected into the hepatic artery become trapped at the precapillary level where they emit potentially lethal internal radiation .This selective mechanism limits exposure to the surrounding normal parenchyma , thereby permitting higher dose delivery than with an external beam [ 14 , 18 ] .", "label": "", "metadata": {}, "score": "67.51099"}
{"text": "Lambert B , Mertens J , Sturm EJ , Stienaers S , Defreyne L , D'Asseler Y : 99mTc - labelled macroaggregated albumin ( MAA ) scintigraphy for planning treatment with 90Y microspheres .", "label": "", "metadata": {}, "score": "67.61122"}
{"text": "This kind of dose / response correlation has already been described by Ho et al .in 1996 [ 22 ] in the classical partition model .", "label": "", "metadata": {}, "score": "67.62831"}
{"text": "10.1055/s-0030 - 1247132 View Article .Marks LB , Yorke ED , Jackson A , Ten Haken RK , Constine LS , Eisbruch A , Bentzen SM , Nam J , Deasy JO : Use of normal tissue complication probability models in the clinic .", "label": "", "metadata": {}, "score": "67.64897"}
{"text": "Wilcoxon - signed ranks test ( nonparametric test ) of variance was used to compare the differences in CT perfusion parameters pre- and post - TACE for different treatment response groups .", "label": "", "metadata": {}, "score": "67.667534"}
{"text": "11 , pp .1664 - 1669 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Garin , L. Lenoir , Y. Rolland , et al . , \" Dosimetry based on 99mTc - macroaggregated albumin SPECT / CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y - loaded glass microspheres : preliminary results , \" Journal of Nuclear Medicine , vol .", "label": "", "metadata": {}, "score": "67.69347"}
{"text": "One of the major drawbacks of the present study is its retrospective design and the lack of control group .Systemic therapy with sorafenib was not started at the same time after 90 Y treatment in all patients who showed progressive disease , and this may have influenced overall survival .", "label": "", "metadata": {}, "score": "67.72571"}
{"text": "[PubMed ] [ DOI ] .Castrucci M , Sironi S , De Cobelli F , Salvioni M , Del Maschio A. Plain and gadolinium - DTPA - enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization .", "label": "", "metadata": {}, "score": "67.7751"}
{"text": "Oct 7 , 2008 ; 14(37 ) : 5738 - 5743 Published online Oct 7 , 2008 .doi : 10.3748/wjg.14.5738 .Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "67.78169"}
{"text": "In this study , we describe the protocol of a multicenter randomized controlled trial aimed at comparing the effectiveness of TACE and 90 Y - RE for treatment of patients with unresectable ( BCLC intermediate stage ) hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "67.789825"}
{"text": "4504 - 4512 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Horger , U. M. Lauer , C. Schraml et al . , \" Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib , \" BMC Cancer , vol .", "label": "", "metadata": {}, "score": "67.9575"}
{"text": "This is because of a phenomenon best described as \" pseudoprogression \" which is an increase in apparent tumor size possibly resulting from central necrosis , peritumoral edema , or intratumoral hemorrhage ( Figures 1 and 2 ) .", "label": "", "metadata": {}, "score": "67.99544"}
{"text": "Only 3 patients did not respond to the treatment .For all 3 , 90 Y glass microspheres were a front - line treatment and their median TD was acceptable , higher than 114 Gy .", "label": "", "metadata": {}, "score": "68.0077"}
{"text": "On the basis of survival analysis , TACE treatment indeed represents a valid therapeutic option for patients with single HCC who are not eligible for curative treatment , as has also been shown by recent series of BCLC - A patients from Barcelona and from Pisa [ 17 , 22 ] .", "label": "", "metadata": {}, "score": "68.01106"}
{"text": "N. Engl .J. Med 1991 , 324 , 1 - 8 .[ Google Scholar ] .Figure 1 .Circulating angiogenic factors ( IL-6 , IL-8 , and VEGF ) were significantly higher in HCC patients than the control groups .", "label": "", "metadata": {}, "score": "68.036575"}
{"text": "All authors declare that they have no conflict of interests or financial interests .References .Jemal , A. ; Bray , F. ; Center , M.M. ; Ferlay , J. ; Ward , E. ; Forman , D. Global cancer statistics .", "label": "", "metadata": {}, "score": "68.16548"}
{"text": "Cancer Res 2003 , 9 , 5996 - 6001 .[ Google Scholar ] .Zhou , L. ; Liu , J. ; Luo , F. Serum tumor markers for detection of hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "68.21217"}
{"text": "954 - 960 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. K. Maddala , L. Stadheim , J. C. Andrews et al . , \" Drop - out rates of patients with hepatocellular cancer listed for liver transplantation : outcome with chemoembolization , \" Liver Transplantation , vol .", "label": "", "metadata": {}, "score": "68.25191"}
{"text": "Cardiovasc Intervent Radiol 2007 , 30 : 6 - 25 .PubMed View Article .Piscaglia F , Terzi E , Cucchetti A , Trimarchi C , Granito A , Leoni S , Marinelli S , Pini P , Bolondi L : Treatment of hepatocellular carcinoma in Child - Pugh B patients .", "label": "", "metadata": {}, "score": "68.28337"}
{"text": "( d ) Maximum intensity projection image of the same phantom scan ( arrow indicates vial sediment ) with the upper PET visual display threshold adjusted to 1 % ( 20 kBq / ml ) to reveal the underlying background noise as an example to readers [ 1 ] .", "label": "", "metadata": {}, "score": "68.325356"}
{"text": "PubMed View Article .Sangro B , D'Avola D , Inarrairaegui M , Prieto J : Transarterial therapies for hepatocellular carcinoma .Expert Opin Pharmacother 2011 , 12 : 1057 - 1073 .", "label": "", "metadata": {}, "score": "68.32885"}
{"text": "Liapi E , Geschwind JF : Transcatheter and ablative therapeutic approaches for solid malignancies .J Clin Oncol 2007 , 25 : 978 - 986 .", "label": "", "metadata": {}, "score": "68.3897"}
{"text": "5 , pp .1552 - 1563 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Leoni , F. Piscaglia , R. Golfieri et al . , \" The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "68.58798"}
{"text": "MATERIALS AND METHODS .Patients .Thirty - nine consecutive patients ( 28 men and 11 women ; age range , 36 - 82 years ; mean , 60.1 years ) with histopathologically proven HCC ( fine needle aspiration ) referred to our center for TACE from September 2007 to June 2008 were included in the study .", "label": "", "metadata": {}, "score": "68.59888"}
{"text": "52 - 64 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. L. Tsai , C. T. Burke , A. S. Kennedy et al . , \" Use of Yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "68.65962"}
{"text": "Oncol 2001 , 19 , 1207 - 1225 .[ Google Scholar ] .Porta , C. ; de Amici , M. ; Quaglini , S. ; Paglino , C. ; Tagliani , F. ; Boncimino , A. ; Moratti , R. ; Corazza , G.R. Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "68.752335"}
{"text": "European association for the study of the liver .J. Hepatol 2001 , 35 , 421 - 430 .[ Google Scholar ] .Miyazaki , S. ; Murase , K. ; Yoshikawa , T. ; Morimoto , S. ; Ohno , Y. ; Sugimura , K. A quantitative method for estimating hepatic blood flow using a dual - input single - compartment model .", "label": "", "metadata": {}, "score": "68.75982"}
{"text": "Radiol 2012 , 22 , 803 - 811 .[ Google Scholar ] .Poon , R.T. ; Fan , S.T. ; Wong , J. Clinical implications of circulating angiogenic factors in cancer patients .", "label": "", "metadata": {}, "score": "68.81265"}
{"text": "Table 1 .Baseline demographic , clinical and tumor characteristics of the whole patient cohort before TACE treatment .Abbreviations : HBV hepatits B virus , HCV hepatitis C virus , TACE transarterial chemoembolization , AFP Alpha - fetoprotein , INR international normalized ratio , CPT Child - Pugh - Turcotte score , BCLC Barcelona Clinic Liver Cancer , MELD Model for end stage liver disease .", "label": "", "metadata": {}, "score": "68.93366"}
{"text": "Objective .The objective of this study is to compare the efficacy and safety of TACE versus 90 Y - RE in patients with intermediate stage HCC .", "label": "", "metadata": {}, "score": "68.99043"}
{"text": "Gy [ 12 , 16 , 21 , 22 ] .Two patients received an intensification of the treatment ( increased injected activity of 30 and 50 % ) regarding the large size of the lesions ( 10.6 and 13.0 cm , resp . ) , their necrotic character and the presence of recently described , favorable predictive dosimetric parameters ( 26 ) .", "label": "", "metadata": {}, "score": "69.015854"}
{"text": "Injected activity varied from 1.31 to 7.51 GBq ( median 2.45 GBq ) .The lowest activity ( 1.31 GBq ) was delivered for the patient with the intratumor shunt in order to hold lung exposure below 30 Gy ( estimated 28.5 Gy ) .", "label": "", "metadata": {}, "score": "69.06206"}
{"text": "View Article .Kavanagh BD , Pan CC , Dawson LA , Das SK , Li XA , Ten Haken RK , Miften M : Radiation dose - volume effects in the stomach and small bowel .", "label": "", "metadata": {}, "score": "69.13049"}
{"text": "Retrospective studies have shown benefit to both TAE and TACE in the treatment of mNET with regard to tumor growth , symptom control , and biochemical surrogates .", "label": "", "metadata": {}, "score": "69.16884"}
{"text": "Most patients were African American men who did not have ascites or extrahepatic metastases ( Table 2 ) .Median tumor size was 8.1 cm ( 2.3 - 17 cm ) , median tumor attenuation was 35 HU ( 20 - 65.2 HU ) , and more than half of the tumors ( 52 % ) demonstrated central hypervascularity pattern .", "label": "", "metadata": {}, "score": "69.356926"}
{"text": "DEBs act as both an occluding agent as well as a drug - loaded carrier , achieving local ischemia and cytotoxic death of the tumor with one device , enabling standardization [ 16 ] .", "label": "", "metadata": {}, "score": "69.37653"}
{"text": "1251 - 1278 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. A. Eisenhauer , P. Therasse , J. Bogaerts et al . , \" New response evaluation criteria in solid tumours : revised RECIST guideline ( version 1.1 ) , \" European Journal of Cancer , vol .", "label": "", "metadata": {}, "score": "69.44307"}
{"text": "Percentages should be read as rows .Abbreviations : CR complete response , HBV hepatits B virus , HCV hepatitis C virus , TACE transarterial chemoembolization , AFP Alpha - fetoprotein , INR international normalized ratio , CPT Child - Pugh - Turcotte score , BCLC Barcelona Clinic Liver Cancer , MELD Model for end stage liver disease .", "label": "", "metadata": {}, "score": "69.46099"}
{"text": "Clinical and tumor characteristics of the whole patient cohort before TACE treatment according to BCLC tumor stage .Abbreviations : BCLC Barcelona Clinic Liver Cancer , TACE transarterial chemoembolization , CPT Child - Pugh - Turcotte score .", "label": "", "metadata": {}, "score": "69.51128"}
{"text": "Thus , initiation / resumption of chemotherapy , possibly combined with extrahepatic local resection / ablation if necessary , appears reasonable .Further considerations concern the endpoints surveyed in Yttrium-90 treatment studies .", "label": "", "metadata": {}, "score": "69.54521"}
{"text": "Due to biophysical and technical differences such as particle size , specific gravity , injected particle load , microembolization , and catheter placement , 99 m Tc MAA can never exactly replicate the post - radioembolization biodistribution of 90 Y resin microspheres [ 12 , 17 ] .", "label": "", "metadata": {}, "score": "69.59719"}
{"text": "Results .Circulating Angiogenic Factors in Patients with HCC and Controls .To evaluate the diagnostic applications of angiogenic factors for predicting patients with HCC , circulating IL-6 , IL-8 , VEGF , and PDGF were analyzed in HCC patients and controls using a receiver - operating characteristic ( ROC ) curve .", "label": "", "metadata": {}, "score": "69.60188"}
{"text": "Table 3 .90 Y dose - response of non - target activity in viscera by MIRD macrodosimetry .Accuracy of tumor predictive dosimetry .Tumor 99 m Tc MAA SPECT / CT predictive dosimetry had a low median relative error of +3.8 % ( mean +6.0 % , 95 % CI -1.2 % to +13.2 % ; Additional file 1 : Figure S4 ) compared to 90 Y PET .", "label": "", "metadata": {}, "score": "69.70822"}
{"text": "Technical success does not necessarily imply clinical success : the former is a qualitative assessment of microsphere biodistribution ; the latter is a quantitative function of dose - response radiobiology .", "label": "", "metadata": {}, "score": "69.72473"}
{"text": "10.2967/jnumed.110.080093 View Article .Bilbao JI , de Martino A , de Luis E , D\u00edaz - Dorronsoro L , Alonso - Burgos A , Mart\u00ednez de la Cuesta A , Sangr B , Garc\u00eda de Jal\u00f3n JA : Biocompatibility , inflammatory response , and recannalization characteristics of nonradioactive resin microspheres : histological findings .", "label": "", "metadata": {}, "score": "69.829216"}
{"text": "Preliminary data for sunitinib , a multikinase inhibitor , for example , demonstrate a promising progression - free survival of 11.4 months versus 5.5 months for placebo .", "label": "", "metadata": {}, "score": "69.837616"}
{"text": "J. Roentgenol 2006 , 186 , 1423 - 1430 .[ Google Scholar ] .Bhatt , R.S. ; Seth , P. ; Sukhatme , V.P. Biomarkers for monitoring antiangiogenic therapy .", "label": "", "metadata": {}, "score": "69.88352"}
{"text": "The overall incidence of RILD , in particular , was estimated to be 0.8 % [ 26 ] .Evidence - based data for treatment decisions in inoperable mNET are not presently available .", "label": "", "metadata": {}, "score": "69.89592"}
{"text": "[ Google Scholar ] .Kim , K.R. ; Moon , H.E. ; Kim , K.W. Hypoxia - induced angiogenesis in human hepatocellular carcinoma .J. Mol .", "label": "", "metadata": {}, "score": "69.91104"}
{"text": "Oliveri RS , Wetterslev J , Gluud C : Transarterial ( chemo)embolisation for unresectable hepatocellular carcinoma .Cochrane Database Syst Rev 2011 , 3 : 1 - 60 .", "label": "", "metadata": {}, "score": "69.98398"}
{"text": "[ Google Scholar ] .McClintock , J.Y. ; Wagner , E.M. Role of IL-6 in systemic angiogenesis of the lung .J. Appl .Physiol 2005 , 99 , 861 - 866 .", "label": "", "metadata": {}, "score": "70.01617"}
{"text": "4 , pp .335 - 345 , 2004 .View at Google Scholar \u00b7 View at Scopus .R. Salem , R. J. Lewandowski , M. F. Mulcahy et al . , \" Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres : a comprehensive report of long - term outcomes , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "70.1345"}
{"text": "Conclusions .Qualitative and quantitative post - radioembolization 90 Y PET / CT are two sides of the same coin and must be interpreted in the context of each other , never in isolation .", "label": "", "metadata": {}, "score": "70.30676"}
{"text": "Selective Internal Radiotherapy with Yttrium-90 Glass Microspheres .The SIRT procedure was performed by percutaneous transarterial injection of radioactive glass microspheres ( \u03b2 -radiation ; activity per microsphere , 2500 Bq ; diameter , 20 to 30 \u03bc m ) into the hepatic artery .", "label": "", "metadata": {}, "score": "70.333176"}
{"text": "We have reported some of the earliest 90 Y dose - response results for resin microspheres expressed in the form of DVHs .90 Y DVHs are able to account for the heterogeneous nature of microsphere biodistribution and are scientifically superior to MIRD macrodosimetry which falsely assumes a uniform dose distribution .", "label": "", "metadata": {}, "score": "70.361465"}
{"text": "10.1118/1.3608909 View Article .Lau WY , Kennedy AS , Kim YH , Lai HK , Lee RC , Leung TW , Liu CS , Salem R , Sangro B , Shuter B , Wang SC : Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres .", "label": "", "metadata": {}, "score": "70.37889"}
{"text": "Statistical Analysis .The ROC curve analysis was performed to examine the diagnostic sensitivity , specificity , and best cutoff values of the circulating angiogenic factors in the HCC patients and controls [ 42 ] .", "label": "", "metadata": {}, "score": "70.466934"}
{"text": "SAS software was used to determine overall survival and progression - free survival using the Kaplan - Meier method .The Kruskal - Wallis test was used to look for differences between controlled and noncontrolled tumors and univariate analysis applied the chi - square test with .", "label": "", "metadata": {}, "score": "70.475464"}
{"text": "Med .Oncol 2011 , 28 , 1012 - 1016 .[ Google Scholar ] .Petreaca , M.L. ; Yao , M. ; Liu , Y. ; Defea , K. ; Martins - Green , M. Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 ( IL-8/CXCL8 ) is required for IL-8/CXCL8-induced endothelial permeability .", "label": "", "metadata": {}, "score": "70.50725"}
{"text": "All authors read and approved the final manuscript .Authors ' Affiliations .Department of Radiology , University Medical Center Utrecht .Department of Gastroenterology and Hepatology , University Medical Center Utrecht .", "label": "", "metadata": {}, "score": "70.5128"}
{"text": "10.1007/BF01084369 View Article .Ho S , Lau WY , Leung TW , Chan M , Johnson PJ , Li AK : Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer .", "label": "", "metadata": {}, "score": "70.51831"}
{"text": "Two of them were downstaged to be within the transplantation criteria [ 19 ] ; one had a liver transplantation but the second one refused it .", "label": "", "metadata": {}, "score": "70.63684"}
{"text": "BF in HCC has been reported to have a possibility for being a biomarker .However , currently , BF has not yet been established as a definitive biomarker of HCC [ 14 ] .", "label": "", "metadata": {}, "score": "70.64061"}
{"text": "145 - 151 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .N. Arslan , M. Emi , E. Alag\u00f6z et al . , \" Selective intraarterial radionuclide therapy with Yttrium-90 ( Y-90 ) microspheres for hepatic neuroendocrine metastases : initial experience at a single center , \" Vojnosanitetski Pregled , vol .", "label": "", "metadata": {}, "score": "70.68269"}
{"text": "10.1186/2191 - 219X-2 - 20 View Article .Gulec SA , Mesoloras G , Stabin M : Dosimetric techniques in 90 Y - microsphere therapy of liver cancer : the MIRD equations for dose calculations .", "label": "", "metadata": {}, "score": "70.71905"}
{"text": "PubMed View Article .Camma C , Schepis F , Orlando A , Albanese M , Shahied L , Trevisani F , Andreone P , Craxi A , Cottone M : Transarterial chemoembolization for unresectable hepatocellular carcinoma : meta - analysis of randomized controlled trials .", "label": "", "metadata": {}, "score": "70.738174"}
{"text": "Lancet 2002 , 359 : 1734 - 1739 .PubMed View Article .Lo CM , Ngan H , Tso WK , Liu CL , Lam CM , Poon RT , Fan ST , Wong J : Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "70.79428"}
{"text": "For patients who dropped out of the study , survival could be calculated by requesting the living status or time of death from the registry offices of the patients ' hometowns , making them assessable for the survival analysis .", "label": "", "metadata": {}, "score": "70.83639"}
{"text": "( a )Before selective internal radiotherapy ( SIRT ) , the tumor ( 10.2 cm ) had poorly defined margins and peripheral enhancement .( b )", "label": "", "metadata": {}, "score": "70.95478"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Llovet , J. Bustamante , A. Castells et al . , \" Natural history of untreated nonsurgical hepatocellular carcinoma : rationale for the design and evaluation of therapeutic trials , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "70.9999"}
{"text": "6 , pp .815 - 820 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. X. Zhu , N. S. Holalkere , A. Muzikansky , K. Horgan , and D. V. Sahani , \" Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma , \" Oncologist , vol .", "label": "", "metadata": {}, "score": "71.013"}
{"text": "847 - 855 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .M. Kalinowski , M. Dressler , A. K\u00f6nig et al . , \" Selective internal radiotherapy with yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors : a prospective single center study , \" Digestion , vol . 79 , no . 3 , pp .", "label": "", "metadata": {}, "score": "71.02939"}
{"text": "10 , pp .1571 - 1593 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Salem and K. G. Thurston , \" Radioembolization with 90 Yttrium microspheres : a state - of - the - art brachytherapy treatment for primary and secondary liver malignancies , part 1 : technical and methodologic considerations , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "71.0539"}
{"text": "Circulating angiogenic factors ( IL-6 , IL-8 , and VEGF ) were significantly higher in HCC patients than the control groups .Figure 2 .The diagnostic sensitivity and specificity of circulating angiogenic factors for HCC were assessed by receiver - operating characteristic ( ROC ) curves and the area under the ROC curve ( AUR ) .", "label": "", "metadata": {}, "score": "71.18002"}
{"text": "SPECT data were reconstructed using an iterative method ( OSEM , 5 iterations , 8 subsets ) with attenuation and scatter correction and then visualized with or without fusion with CT scan data .", "label": "", "metadata": {}, "score": "71.227905"}
{"text": "The SIRT dose was determined from CT - based liver volumetric analysis .Desired calculated doses per tumor - containing lobe ranged from 80 to 150 Gy [ 19 - 21 ] .", "label": "", "metadata": {}, "score": "71.24208"}
{"text": "6 , pp .1029 - 1035 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .S.G. Meranze , P. R. Bream , and E. Grzeszczak , \" Phase II clinical trial of yttrium-90 resin microspheres for the treatment of metastatic neuroendocrine tumor , \" in Proceedings of the Society of Interventional Radiology ( SIR ) 32nd Annual Scientific Meeting , 2007 , abstract 422 .", "label": "", "metadata": {}, "score": "71.27539"}
{"text": "( a )Catheter - directed CT angiogram of the anterior branch of the right hepatic artery , supplying segments V and VIII , demonstrates contrast enhancement of a large portal vein tumor thrombus ( arrow ) .", "label": "", "metadata": {}, "score": "71.27673"}
{"text": "In two patients , a mean dose of 18 Gy to the stomach was asymptomatic , 49 Gy caused gastritis , 65 Gy caused ulceration , and 53 Gy caused duodenitis .", "label": "", "metadata": {}, "score": "71.35462"}
{"text": "Flamen P , Vanderlinden B , Delatte P , Ghanem G , Ameye L , Van Den Eynde M , Hendlisz A : Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with yttrium-90 labeled resin microspheres .", "label": "", "metadata": {}, "score": "71.38468"}
{"text": "Rossi P , Salvatori FM , D'Erme M , Maradei A , Rossi M , Santoro P , Mastantuono M , Gualdi G. [ Therapy of hepatic carcinoma by the intra - arterial injection of lipiodol , antineoplastic agents and gelfoam].", "label": "", "metadata": {}, "score": "71.49444"}
{"text": "S115-S120 , 2004 .View at Google Scholar \u00b7 View at Scopus .R. Salem and K. G. Thurston , \" Radioembolization with 90 Yttrium microspheres : a state - of - the - art brachytherapy treatment for primary and secondary liver malignancies , part 2 : special topics , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "71.54289"}
{"text": "PubMed View Article .Golfieri R , Renzulli M , Mosconi C , Forlani L , Giampalma E , Piscaglia F , Trevisani F , Bolondi L , Bologna Liver Oncology Group ( BLOG ) : Hepatocellular carcinoma responding to superselective transarterial chemoembolization : an issue of nodule dimension ?", "label": "", "metadata": {}, "score": "71.65011"}
{"text": "Phys Med Biol 2008 , 53 : 4213 - 4230 .10.1088/0031 - 9155/53/16/001 View Article .Stabin MG , Eckerman KF , Ryman JC , Williams LE : Bremsstrahlung radiation dose in yttrium-90 therapy applications .", "label": "", "metadata": {}, "score": "71.73259"}
{"text": "176 - 181 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. Sangro , L. Carpanese , R. Cianni , et al . , \" Survival after yttrium \u2010 90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages : a European evaluation , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "71.80216"}
{"text": "Bolondi L , Burroughs A , Dufour JF , Galle PR , Mazzaferro V , Piscaglia F , Raoul JL , Sangro B : Heterogeneity of patients with intermediate ( BCLC B ) hepatocellular carcinoma : proposal for a subclassification to facilitate treatment decisions .", "label": "", "metadata": {}, "score": "71.96834"}
{"text": "This point needs to be highlighted in the next future as MAA SPECT / CT - based dosimetry results are available after the diagnostic angiography and before treatment and we will further explore it by continuing publishing the data of our patients showing lobar HCC with ipsilateral PVVT .", "label": "", "metadata": {}, "score": "71.968475"}
{"text": "However , their study did not find any significant correlation between other perfusion parameters ( BF , BV , HAF , and PS ) and AFP levels [ 16 ] .", "label": "", "metadata": {}, "score": "72.06011"}
{"text": "90 Y PET / CT is a descriptive modality to assess post - implantation microsphere biodistribution , where all inadvertent or adverse findings have already irreversibly occurred .", "label": "", "metadata": {}, "score": "72.10893"}
{"text": "55 , no . 2 , pp .74 - 108 , 2005 .View at Google Scholar \u00b7 View at Scopus .M. Pirisi , C. Avellini , C. Fabris et al . , \" Portal vein thrombosis in hepatocellular carcinoma : age and sex distribution in an autopsy study , \" Journal of Cancer Research and Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "72.11974"}
{"text": "[PubMed ] [ DOI ] .Okusaka T , Okada S , Ueno H , Ikeda M , Yoshimori M , Shimada K , Yamamoto J , Kosuge T , Yamasaki S , Iwata R. Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "72.144356"}
{"text": "70 months median survival with 63 % ORR and 23 % stable disease were demonstrated , with most deaths due to progression of extrahepatic disease .", "label": "", "metadata": {}, "score": "72.213165"}
{"text": "Low - grade activity seen in the adjacent right liver lobe is due to 90 Y radioembolization of a segment IV metastasis .( d ) Follow - up contrast - enhanced CT of the abdomen at 9.5 months shows a moderate size reduction to 7.6 \u00d7 4.6 cm , representing a partial response .", "label": "", "metadata": {}, "score": "72.27323"}
{"text": "Intended tumor mean doses by predictive dosimetry were compared to doses by 90 Y PET .Results .Phantom studies demonstrated near - perfect detector linearity and high tumor quantitative accuracy .", "label": "", "metadata": {}, "score": "72.28069"}
{"text": "These VOIs were then used to calculate the volumes of the liver and the tumor ( expressed in mL ) in addition to the total activity ( expressed in counts ) contained in the liver ( CP L ) and tumor ( CP tum ) .", "label": "", "metadata": {}, "score": "72.35359"}
{"text": "J. Radiol 2008 , 73 , 148 - 152 .[ Google Scholar ] .J. Comput .Assist .Tomogr 2008 , 32 , 855 - 858 .", "label": "", "metadata": {}, "score": "72.39925"}
{"text": "Acknowledgments .The authors thank I - Shou Chang for assistance in statistical analysis .This study was supported by grants NSC 99 - 2320-B-400 - 001 from National Science Council , Taiwan , VGHKS98 - 067 and VGHKS99 - 094 from Kaohsiung Veterans General Hospital , Kaohsiung , Taiwan .", "label": "", "metadata": {}, "score": "72.55545"}
{"text": "1590 - 1602 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus .C. Q. Cao , T. D. Yan , L. Bester , W. Liauw , and D. L. Morris , \" Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases , \" British Journal of Surgery , vol .", "label": "", "metadata": {}, "score": "72.56428"}
{"text": "31 , no .4 , pp .840 - 845 , 2000 .View at Google Scholar \u00b7 View at Scopus .J. L. Raoul , B. Sangro , A. Forner et al . , \" Evolving strategies for the management of intermediate - stage hepatocellular carcinoma : available evidence and expert opinion on the use of transarterial chemoembolization , \" Cancer Treatment Reviews , vol .", "label": "", "metadata": {}, "score": "72.577896"}
{"text": "Llovet JM , Fuster J , Bruix J : The Barcelona approach : diagnosis , staging , and treatment of hepatocellular carcinoma .Liver Transpl 2004 , 10 : S115-S120 .", "label": "", "metadata": {}, "score": "72.62048"}
{"text": "200 - 208 , 1965 .View at Google Scholar . A. S. Kennedy , C. Nutting , D. Coldwell , J. Gaiser , and C. Drachenberg , \" Pathologic response and microdosimetry of 90 Y microspheres in man : review of four explanted whole livers , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "72.63593"}
{"text": "The plasma was used for analyzing the angiogenic array performed using the microsphere - based Bio - Plex Suspension Array system ( Bio - Rad Laboratories , Hercules , CA , USA ) .", "label": "", "metadata": {}, "score": "72.80709"}
{"text": "1121 - 1130 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed .O. Soreide , T. Berstad , A. Bakka et al . , \" Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors , \" Surgery , vol . 111 , no . 1 , pp .", "label": "", "metadata": {}, "score": "72.90705"}
{"text": "We scanned the microsphere sediment and not its fresh suspension to avoid issues with microsphere sedimentation during PET acquisition .In effect , each vial sediment represents a small heterogeneous volume of high 90 Y radioconcentration , simulating a small tumor implanted with a high and heterogeneous density of 90 Y resin microspheres .", "label": "", "metadata": {}, "score": "73.25601"}
{"text": "5 , pp .1494 - 1500 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed \u00b7 View at Scopus . A. Riaz , R. J. Lewandowski , L. M. Kulik et al . , \" Complications following radioembolization with yttrium-90 microspheres : a comprehensive literature review , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "73.458435"}
{"text": "Tolerance was good for all patients .Adverse effects were grade 3 or less on the CTCAEv3.0 scale .Three patients ( 16.6 % ) complained of abdominal , three ( 16.6 % ) developed asthenia , and one ( 5.5 % ) anorexia .", "label": "", "metadata": {}, "score": "73.47357"}
{"text": "The database was closed on October 1 , 2011 , the date at which all data were censored .Progression - free survival ( PFS ) was measured from the date of the first treatment until the date of progression in the treated liver .", "label": "", "metadata": {}, "score": "73.55963"}
{"text": "A CR at one month was obtained in 95/148 ( 64 % ) patients , a PR in 39 ( 26 % ) , SD in 1 patient and PD in 10 ( 7 % ) .", "label": "", "metadata": {}, "score": "73.713974"}
{"text": "The peripheral blood of angiogenic factors and alpha - fetoprotein ( AFP ) from eight sex- and age - matched healthy controls ( seven men and one woman , mean age 55 years ) were also analyzed .", "label": "", "metadata": {}, "score": "73.74548"}
{"text": "[ Google Scholar ] .Fu , Q. ; Zhu , J. ; van Eyk , J.E. Comparison of multiplex immunoassay platforms .Clin .Chem 2010 , 56 , 314 - 318 .", "label": "", "metadata": {}, "score": "74.02482"}
{"text": "A total of 70-mL of nonionic iodinated contrast agent ( Isovue ; Bracco , Princeton , NJ , USA ) ( 300 mg of iodine / mL ) was injected at a rate of 3.5 mL / s followed by saline flush using an 18-gauge intravenous cannula at the right elbow .", "label": "", "metadata": {}, "score": "74.142105"}
{"text": "Sugimachi , K. ; Tanaka , S. ; Terashi , T. ; Taguchi , K. ; Rikimaru , T. The mechanisms of angiogenesis in hepatocellular carcinoma : Angiogenic switch during tumor progression .", "label": "", "metadata": {}, "score": "74.2115"}
{"text": "Circulating IL-6 also plays a more important role in the tumorigenesis than angiogenesis of HCC [ 45 ] .Similar to the previous study [ 13 ] , we did not find a significant difference in the BF of HCC in patients with low and high AFP levels .", "label": "", "metadata": {}, "score": "74.27201"}
{"text": "criteria ; 10 % of the patients demonstrated partial response , while 10 % showed disease progression ( Table 4 ) .Only nine patients were response evaluable by MASS criteria ; of theses 9 patients , 44 % demonstrated favorable response while 22 % and 33 % of the patients demonstrated indeterminate and unfavorable response , respectively ( Table 4 ) .", "label": "", "metadata": {}, "score": "74.38046"}
{"text": "References .European Association For The Study Of The Liver , European Organisation For Research And Treatment Of Cancer : EASL - EORTC clinical practice guidelines : management of hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "74.42001"}
{"text": "Each of the categorical covariates was tested for association with progression - free and overall survival using the log - rank test .Continuous covariates were tested using Cox proportional hazards regression model .", "label": "", "metadata": {}, "score": "74.44449"}
{"text": "599 - 609 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. M. Llovet , J. Fuster , and J. Bruix , \" The Barcelona approach : diagnosis , staging , and treatment of hepatocellular carcinoma , \" Liver Transplantation , vol .", "label": "", "metadata": {}, "score": "74.44488"}
{"text": "The value of PVP was further increased in HCC of the PD group after treatment , suggesting involvement of hepatic portal vein during tumor advancement .", "label": "", "metadata": {}, "score": "74.488464"}
{"text": "( a ) , ( b )Before treatment with selective internal radiotherapy , tumor thrombus extended from the hepatocellular carcinoma ( liver segment VI ) to the right hemiportal vein ( a ) and main portal vein ( b ) .", "label": "", "metadata": {}, "score": "74.84392"}
{"text": "10.1016/j.ijrobp.2004.09.004 View Article .Van de Wiele C , Maes A , Brugman E , D'Asseler Y , De Spiegeleer B , Mees G , Stellamans K : SIRT of liver metastases : physiological and pathophysiological considerations .", "label": "", "metadata": {}, "score": "74.950775"}
{"text": "Briefly , the images were acquired after a seven - second delay from the start of the injection , and 15 scans with an interval of two seconds were then acquired ; six scans with an interval of seven seconds were then acquired twice .", "label": "", "metadata": {}, "score": "74.97005"}
{"text": "All 5-\u03bcm - thick sections were deparaffinized and rehydrated .After antigen retrieval , the slides were blocked and then incubated with anti - CD31 Ab ( 1:200 , rabbit polyclonal , Abcam , Cambridge , MA , USA ) .", "label": "", "metadata": {}, "score": "74.99055"}
{"text": "On the other hand , preparatory angiography mapping , embolization , and treatment simulation are a necessary first step in TARE workup .It is conceivable that Yttrium-90 microspheres can be held in reserve , so to speak , for further repeated use to establish prolonged disease control .", "label": "", "metadata": {}, "score": "75.08554"}
{"text": "PubMed View Article .El - Serag HB : Hepatocellular carcinoma : recent trends in the United States .Gastroenterology 2004 , 127 : S27-S34 .", "label": "", "metadata": {}, "score": "75.1866"}
{"text": "TARE ( see Table 1 ) is at least comparable to TA(C)E in effectiveness [ 13 , 14 ] .An advantage of the TARE protocol is the generally single treatment to achieve this effect , while TA(C)E is generally applied multiple times .", "label": "", "metadata": {}, "score": "75.208824"}
{"text": "For these patients with advanced - stage HCC , palliative systemic treatments may be proposed [ 8 ] : sorafenib is currently the gold standard , even if debated , allowing significant improvement in time to progression and survival [ 9 ] .", "label": "", "metadata": {}, "score": "75.27351"}
{"text": "All authors read and approved the final manuscript .Authors ' Affiliations .Department of Nuclear Medicine and PET , Singapore General Hospital .Department of Nuclear Medicine , Sir Charles Gairdner Hospital .", "label": "", "metadata": {}, "score": "75.425255"}
{"text": "Gy to the volume to be treated ( i.e. , the injected liver , usually one lobe ) .This dose was calculated according to the following formula , based on the Medical Internal Radiation Dose ( MIRD ) formalism , previously described and widely used [ 12 , 16 , 21 , 22 ] : .", "label": "", "metadata": {}, "score": "75.47415"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Forner , C. Ayuso , M. Varela et al . , \" Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma : are response evaluation criteria in solid tumors reliable ? \"", "label": "", "metadata": {}, "score": "75.474464"}
{"text": "Projected median survival times were 28 and 22 months , respectively ( not statistically significant difference ) , with the majority of patients alive at time of study publication [ 22 ] .", "label": "", "metadata": {}, "score": "75.653534"}
{"text": "MR made a substantial contribution in the acquisition and analysis of data .LB : revised the paper critically and gave approval of the submitted and final versions .", "label": "", "metadata": {}, "score": "75.69206"}
{"text": "Keywords : . hepatocellular carcinoma ; blood flow ; circulating angiogenic factors ; CT perfusion ; interleukin 8 .Introduction .Hepatocellular carcinoma ( HCC ) is the third most common cause of cancer - related death worldwide with six million new cases diagnosed annually [ 1 ] .", "label": "", "metadata": {}, "score": "75.73519"}
{"text": "Browne E , Firestone RB : Table of Radioactive Isotopes .New York : Wiley ; 1986 .Lencioni R , Llovet JM : Modified RECIST ( mRECIST ) assessment for hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "75.82718"}
{"text": "Portal vein tumor thrombosis ( PVTT ) is a common complication of hepatocellular carcinoma ( HCC ) and has a negative impact on prognosis .This characteristic feature led to the rationale of the present trial designed to assess the efficacy and the safety of yttrium-90 glass - microsphere treatment for advanced - stage lobar HCC with ipsilateral PVTT .", "label": "", "metadata": {}, "score": "75.97202"}
{"text": "A 63-year - old man with hepatocellular carcinoma .The right lobe of the liver was extensively involved with tumor , which had multiple satellite nodules and poor margins .", "label": "", "metadata": {}, "score": "76.04172"}
{"text": "Their effectiveness , however , tends to diminish over time due to tachyphylaxis and disease progression .An antiproliferative effect has been ascribed to somatostatin analogs on their own [ 4 ] .", "label": "", "metadata": {}, "score": "76.061554"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Edeline , E. Boucher , Y. Rolland et al . , \" Comparison of tumor response by Response Evaluation Criteria in Solid Tumors ( RECIST ) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma , \" Cancer , vol .", "label": "", "metadata": {}, "score": "76.14484"}
{"text": "Department of Gastroenterology and Hepatology , Leiden University Medical Center .Department of Nuclear Medicine , Leiden University Medical Center .References .Parkin DM , Bray F , Ferlay J , Pisani P : Global cancer statistics , 2002 .", "label": "", "metadata": {}, "score": "76.433"}
{"text": "5 , pp .610 - 616 , 2002 .View at Google Scholar \u00b7 View at Scopus . E. S. Delpassand , J. Sims - Mourtada , H. Saso et al . , \" Safety and efficacy of radionuclide therapy with high - activity in-111 pentetreotide in patients with progressive neuroendocrine tumors , \" Cancer Biotherapy and Radiopharmaceuticals , vol .", "label": "", "metadata": {}, "score": "76.43492"}
{"text": "A P- value of less than .05 will be considered to be statistically significant .Analyses will be performed according to the intention to treat principle .", "label": "", "metadata": {}, "score": "76.654724"}
{"text": "Mazzaferro V , Regalia E , Doci R , Andreola S , Pulvirenti A , Bozzetti F , Montalto F , Ammatuna M , Morabito A , Gennari L : Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis .", "label": "", "metadata": {}, "score": "76.71255"}
{"text": "Bayesian analysis was applied to a multivariate Cox proportional hazards regression model to identify a parsimonious set of statistically significant covariates .Statistical significance was defined by .", "label": "", "metadata": {}, "score": "76.79411"}
{"text": "Primary outcome .The primary outcome will be Time to Progression ( TTP ) , defined as the time elapsed since the start of treatment until the determination of progressive disease .", "label": "", "metadata": {}, "score": "76.85497"}
{"text": "10.1007/s00270 - 009 - 9592 - 9 View Article .Strigari L , Sciuto R , Rea S , Carpanese L , Pizzi G , Soriani A , Iaccarino G , Benassi M , Ettorre GM , Maini CL : Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90 Y - SIR spheres : radiobiologic considerations .", "label": "", "metadata": {}, "score": "77.052635"}
{"text": "1208 - 1236 , 2005 .View at Google Scholar . A. Cheng , Y. Kang , Z. Chen et al . , \" Efficacy and safety of sorafenib in patients in the Asia - Pacific region with advanced hepatocellular carcinoma : a phase III randomised , double - blind , placebo - controlled trial , \" The Lancet Oncology , vol .", "label": "", "metadata": {}, "score": "77.37444"}
{"text": "A 77-year - old man with hepatocellular carcinoma ( 6.4 cm ) in liver segment VII that had well - defined margins .( c )", "label": "", "metadata": {}, "score": "77.385445"}
{"text": ": Hepatocellular carcinoma ( HCC ) is a highly vascular tumor through the process of angiogenesis .To evaluate more non - invasive techniques for assessment of blood flow ( BF ) in HCC , this study examined the relationships between BF of HCC measured by computer tomography ( CT ) perfusion imaging and four circulating angiogenic factors in HCC patients .", "label": "", "metadata": {}, "score": "77.43292"}
{"text": "Oncol 2008 , 19 , 353 - 358 .[ Google Scholar ] .Kim , S.J. ; Choi , I.K. ; Park , K.H. ; Yoon , S.Y. ; Oh , S.C. ; Seo , J.H. ; Choi , C.W. ; Kim , B.S. ; Shin , S.W. ; Kim , Y.H. ; et al .", "label": "", "metadata": {}, "score": "77.43386"}
{"text": "First results are pending .Ethical approval .The study protocol has been approved by the ethical boards of the participating hospitals .Abbreviations .Technetium-99 m - labeled macro aggregated albumin .", "label": "", "metadata": {}, "score": "77.51011"}
{"text": "Authors ' contributions .ET made a substantial contribution in the acquisition , analysis and interpretation of data .She helped in drafting the paper .", "label": "", "metadata": {}, "score": "77.587265"}
{"text": "[ Google Scholar ] .Heldin , C.H. ; Westermark , B. Mechanism of action and in vivo role of platelet - derived growth factor .", "label": "", "metadata": {}, "score": "77.671074"}
{"text": "25 - 34 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. A. Ingold , G. B. Reed , H. S. Kaplan , and M. A. Bagshaw , \" Radiation hepatitis , \" The American Journal of Roentgenology , Radium Therapy , and Nuclear Medicine , vol .", "label": "", "metadata": {}, "score": "77.79628"}
{"text": "Peer reviewer : Dr. Serdar Karakose , Professor , Department of Radiology , Meram Medical Faculty , Selcuk University , Konya 42080 , Turkey .S- Editor Zhong XY L- Editor Wang XL E- Editor Ma WH .", "label": "", "metadata": {}, "score": "77.80008"}
{"text": "255 - 263 , 2012 .View at Google Scholar .55 , no . 2 , pp .168 - 197 , 2011 .View at Google Scholar \u00b7 View at Scopus Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the Liver .", "label": "", "metadata": {}, "score": "78.11121"}
{"text": "The activity is chosen to deliver an absorbed dose of about 120 Gy to the treatment zone in patients with no manifest risk factors for subsequent liver decomposition .", "label": "", "metadata": {}, "score": "78.47853"}
{"text": "352 - 361 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Faivre , M. Zappa , V. Vilgrain et al . , \" Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib , \" Clinical Cancer Research , vol .", "label": "", "metadata": {}, "score": "78.63994"}
{"text": "What is more , it appears that the primarily one - time treatments with TARE compare favorably to usually multiple procedures required TA(C)E regimens .SIR - spheres come with premarket approval ( PMA ) for unresectable hepatic metastases of colorectal cancer in the United States and may be utilized \" off - label \" for other tumors without prejudice under the using physicians discretion authority and responsibility .", "label": "", "metadata": {}, "score": "78.74942"}
{"text": "The extended use of TARE , on the other hand , would likely not reach the number of regular TA(C)E sessions .Similar advantages also apply to side effects and outpatient flexibility .", "label": "", "metadata": {}, "score": "78.78511"}
{"text": "For patients with advanced hepatocellular carcinoma who are not candidates for curative or liver - directed therapies , targeted molecular therapy with sorafenib may improve survival [ 10 , 11 ] .", "label": "", "metadata": {}, "score": "78.979126"}
{"text": "PubMed View Article .Vente MA , Wondergem M , van der Tweel I , van den Bosch MA , Zonnenberg BA , Lam MG , van Het Schip AD , Nijsen JF :", "label": "", "metadata": {}, "score": "79.00285"}
{"text": "The counting field was captured with a digital camera at five regions of the predominantly vascular areas ( hot spots ) under a high - power field ( \u00d7200 , 0.62 mm 2 per field ) .", "label": "", "metadata": {}, "score": "79.13573"}
{"text": "Department of Radiology , Leiden University Medical Center .References .EJNMMI Res 2013 , 3 : 56 .10.1186/2191 - 219X-3 - 56 View Article .", "label": "", "metadata": {}, "score": "79.38394"}
{"text": "1425 - 1439 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Salem and K. G. Thurston , \" Radioembolization with yttrium-90 microspheres : a state - of - the - art brachytherapy treatment for primary and secondary liver malignancies , part 3 : comprehensive literature review and future direction , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "79.754"}
{"text": "Our finding suggests that IL-8 is not only a detection marker of HCC but also correlated with BF of HCC .We did not observe a significant correlation between the other three circulating angiogenic factors ( IL-6 , VEGF , PDGF ) and BF measured by CT perfusion , even though IL-6 and VEGF did show good discrimination between patients with HCC and controls .", "label": "", "metadata": {}, "score": "80.09582"}
{"text": "868 - 878 , 2011 .View at Google Scholar .V. Mazzaferro , C. Sposito , S. Bhoori et al . , \" Yttrium(90 ) radioembolization for intermediate - advanced hepatocarcinoma : a phase II study , \" Hepatology .", "label": "", "metadata": {}, "score": "80.098854"}
{"text": "[ Google Scholar ] .Naugler , W.E. ; Sakurai , T. ; Kim , S. ; Maeda , S. ; Kim , K. ; Elsharkawy , A.M. ; Karin , M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production .", "label": "", "metadata": {}, "score": "80.10529"}
{"text": "Yttrium-90 radioembolization ( 90 Y - RE ) involves the transarterial administration of minimally embolic microspheres loaded with Yttrium-90 , a \u03b2 - emitting isotope , delivering selective internal radiation to the tumor .", "label": "", "metadata": {}, "score": "80.13454"}
{"text": "71 - 81 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Salem , R. Lewandowski , C. Roberts et al . , \" Use of Yttrium-90 glass microspheres ( therasphere ) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis , \" Journal of Vascular and Interventional Radiology , vol .", "label": "", "metadata": {}, "score": "80.14668"}
{"text": "Additionally , the MASS criteria were initially developed in patients with renal cell carcinoma who were treated with tyrosine kinase therapy .In summary , in hypervascular tumors such as hepatocellular carcinoma , imaging response criteria that account for changes in tumor morphology , percentage of tumor necrosis , attenuation , and size may be more sensitive to the antitumor effects of SIRT than criteria based on size alone .", "label": "", "metadata": {}, "score": "80.21391"}
{"text": "90 Y radioembolization of an organ other than the liver .KIT - negative GIST with bulky metastasis to the right adrenal gland , refractory to tyrosine kinase inhibitors .", "label": "", "metadata": {}, "score": "80.389595"}
{"text": "Furthermore , the vast majority of the studies investigating the efficacy of TACE excluded patients with advanced liver disease , PVT and impaired PS ; therefore , there was also no evidence of the impact of TACE in those categories of patients [ 20 ] .", "label": "", "metadata": {}, "score": "80.557"}
{"text": "90 Y DVH dose - response of the right kidney is presented in Table 4 .All results were in keeping with published experiences of external beam radiotherapy [ 29 , 30 ] .", "label": "", "metadata": {}, "score": "80.587585"}
{"text": "To delicately measure the change in BF between HCC and its surrounding liver parenchyma , we calculated the HCC - parenchyma ratio ( HCC / parenchyma ) of the BF parameters .", "label": "", "metadata": {}, "score": "80.60191"}
{"text": "10.1016/j.ijrobp.2008.12.058 View Article .J Nucl Med Radiat Ther 2012 , 3 : 122 .View Article .Q J Nucl Med Mol Imaging 2011 , 55 : 168 - 197 .", "label": "", "metadata": {}, "score": "80.61513"}
{"text": "Quantitative phantom studies were first performed to confirm detector linearity of our time - of - flight lutetium - yttrium - oxyorthosilicate ( LYSO ) system and for comparison with a radiopharmacy dose calibrator .", "label": "", "metadata": {}, "score": "80.684654"}
{"text": "40 % partial response was seen at 6 months and 2 out of 3 patients experienced symptomatic improvement , and average quality of life climbed to general - population levels by 6 months .", "label": "", "metadata": {}, "score": "80.69798"}
{"text": "Only eight patients fulfilled all tumor selection criteria : patients 1 , 2 , 8 , 9 , 17 , 19 , 21 , and 23 .", "label": "", "metadata": {}, "score": "80.71065"}
{"text": "As 90 Y radioembolization is a brachytherapy delivered by \u03b2 - -emitting microspheres , any tissue response is expected to follow predictable dose - response radiobiology .", "label": "", "metadata": {}, "score": "80.735504"}
{"text": "Methods .Phantom quantification .An institutional review board approval was obtained for the conduct and publication of this retrospective report ( CIRB 2010/781/C , SingHealth , Singapore ) .", "label": "", "metadata": {}, "score": "80.78737"}
{"text": "He helped in drafting the paper , revising it critically and gave approval of the submitted and final versions .FF made a substantial contribution in the acquisition of data .", "label": "", "metadata": {}, "score": "80.81865"}
{"text": "A correlation between the HCC - parenchyma ratio of arterial BF and level of circulating IL-8 .Figure 5 .A correlation between the HCC - parenchyma ratio of arterial BF and level of circulating IL-8 .", "label": "", "metadata": {}, "score": "80.92733"}
{"text": "Yttrium-90 radioembolization .Yttrium-90 radioembolization ( 90 Y - RE ) is a relatively recently developed technique which involves the transarterial administration of minimally embolic microspheres loaded with Yttrium-90 , a \u03b2 - emitting isotope , delivering selective internal radiation to the tumor .", "label": "", "metadata": {}, "score": "80.95741"}
{"text": "Overall , both TAE and TACE appear to elicit similar responses from NET liver metastases , suggesting relative primacy of the embolic effect [ 2 , 14 ] .", "label": "", "metadata": {}, "score": "81.24065"}
{"text": "CB , JAB , RJF , and TSTC were involved in the data analysis and manuscript preparation .PKHC was involved in the clinical care and manuscript preparation .", "label": "", "metadata": {}, "score": "81.61849"}
{"text": "This article is an open - access article which was selected by an in - house editor and fully peer - reviewed by external reviewers .", "label": "", "metadata": {}, "score": "81.89215"}
{"text": "PubMed View Article .Position paper of the Italian Association for the Study of the Liver ( AISF ) : The multidisciplinary clinical approach to hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "81.98161"}
{"text": "Biol .Cell 2007 , 18 , 5014 - 5023 .[ Google Scholar ] .Nilsson , M.B. ; Langley , R.R. ; Fidler , I.J. Interleukin-6 , secreted by human ovarian carcinoma cells , is a potent proangiogenic cytokine .", "label": "", "metadata": {}, "score": "82.05009"}
{"text": "The circulating IL-6 has higher diagnostic accuracy than serum AFP titers in HCC patients [ 25 ] .VEGF is a secreted cytokine that positively regulates tumor angiogenesis , and patients with HCC have higher level of circulating VEGF [ 26 , 34 ] .", "label": "", "metadata": {}, "score": "82.05414"}
{"text": "In the lower right panel , the red curve represented the enhancing change of the target artery .The blue curve represents the target portal vein , and the yellow curve indicates the region of interest ( ROI ) of the HCC .", "label": "", "metadata": {}, "score": "82.17536"}
{"text": "In the lower right panel , the red curve represented the enhancing change of the target artery .The blue curve represents the target portal vein , and the yellow curve indicates the region of interest ( ROI ) of the HCC .", "label": "", "metadata": {}, "score": "82.17536"}
{"text": "Authors ' original submitted files for images .Below are the links to the authors ' original submitted files for images .Competing interests .YHK , ASWG , KHT , and PKHC received research funding from Sirtex Medical Singapore .", "label": "", "metadata": {}, "score": "82.49988"}
{"text": "TACE .TACE will be performed with drug - eluting beads , that is , polyvinyl alcohol - based microspheres ( DC Bead \u00ae , Biocompatibles , Farnham , UK ) , 100 to 300 \u03bcm in diameter , loaded with the chemotherapeutic agent doxorubicin .", "label": "", "metadata": {}, "score": "82.55264"}
{"text": "NCT01381211 .Background .Hepatocellular carcinoma ( HCC ) , a primary malignant tumor of the liver , is the sixth most common cancer worldwide with an incidence of 626,000 new patients a year , and the third most common cause of cancer - related death [ 1 ] .", "label": "", "metadata": {}, "score": "82.58667"}
{"text": "11 , pp .1782 - 1787 , 1994 .View at Google Scholar \u00b7 View at Scopus .P. Hilgard , M. Hamami , A. E. Fouly et al . , \" Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma : european experience on safety and long - term survival , \" Hepatology , vol .", "label": "", "metadata": {}, "score": "82.71479"}
{"text": "Branches feeding gastro - intestinal organs arising from the hepatic arteries must be identified .Radioactive microspheres , administered into the hepatic artery , should be prevented from ending up in extrahepatic organs via this route .", "label": "", "metadata": {}, "score": "82.89174"}
{"text": "The total 90 Y activity ( kBq ) within the VOI was calculated as the product of its mean radioconcentration ( kBq / ml ) and its volume ( cm 3 ) .", "label": "", "metadata": {}, "score": "82.9866"}
{"text": "Coincidence imaging of low - abundance yttrium-90 ( 90 Y ) internal pair production by 90 Y positron emission tomography with integrated computed tomography ( PET / CT ) achieves high - resolution imaging of post - radioembolization microsphere biodistribution .", "label": "", "metadata": {}, "score": "83.01056"}
{"text": "329 - 338 , 1999 .View at Google Scholar \u00b7 View at Scopus . F. Perrone , \" Prospective validation of the CLIP score : a new prognostic system for patients with cirrhosis and hepatocellular carcinoma .", "label": "", "metadata": {}, "score": "83.0478"}
{"text": "Department of Pathology , Kaohsiung Veterans General Hospital , Kaohsiung 813 , Taiwan .Department of Medical Laboratory Sciences and Biotechnology , Fooyin University , Kaohsiung 807 , Taiwan .", "label": "", "metadata": {}, "score": "83.19951"}
{"text": "An AUR of 1 indicated excellent diagnostic performance , while 0.5 indicated a performance no better than chance .Pairwise comparisons of AUR for various angiogenic factors were performed .", "label": "", "metadata": {}, "score": "83.30632"}
{"text": "Materials and Methods .Patients .This study was a retrospective review of 23 patients who had hepatocellular carcinoma and who underwent SIRT with yttrium-90 glass microspheres between 2008 and 2011 at Karmanos Cancer Center , a tertiary care center .", "label": "", "metadata": {}, "score": "83.51898"}
{"text": "The impact of TACE on the serum levels of albumin , bilirubin , the international normalized ratio ( INR ) , creatinine and the MELD score the day after TACE is reported in Figure 2 .", "label": "", "metadata": {}, "score": "83.629745"}
{"text": "Although 90 Y - RE is increasingly used in clinical practice , there is no high quality clinical evidence to justify this .Lewandowsky et al .", "label": "", "metadata": {}, "score": "83.72011"}
{"text": "[PubMed ] [ DOI ] .Tsui EY , Chan JH , Cheung YK , Cheung CC , Tsui WC , Szeto ML , Lau KW , Yuen MK , Luk SH .", "label": "", "metadata": {}, "score": "83.840454"}
{"text": "10.2967/jnumed.111.095232 View Article .Sirtex Technology Pty Ltd : Pilot study of selective internal radiation therapy ( SIRT ) with yttrium-90 resin microspheres ( SIR - Spheres microspheres ) in patients with renal cell carcinoma ( STX0110 , \" RESIRT \" ) .", "label": "", "metadata": {}, "score": "83.91468"}
{"text": "These criteria define adverse events on a scale from 1 to 5 , corresponding to severity ( grade 1 : mild , grade 2 : moderate , grade 3 : severe , grade 4 : life - threatening or disabling , grade 5 : resulting in death ) .", "label": "", "metadata": {}, "score": "83.982544"}
{"text": "Statistical analysis .Data are presented as median , mean , range , and 95 % confidence intervals ( CI ) , where applicable .Results .", "label": "", "metadata": {}, "score": "84.09326"}
{"text": "Little toxicity was observed , with the authors noting comparable to better toleration of TARE compared to TACE [ 23 ] .Another study with Yttrium-90 resin microspheres also had quality of life as an endpoint and could demonstrate significant improvement of quality of life [ 18 ] .", "label": "", "metadata": {}, "score": "84.16519"}
{"text": "Hepatocellular carcinoma ( HCC ) is a common cancer with an estimated annual incidence of 600,000 worldwide [ 1 ] .Patients with PVTT involving the portal trunk or main branch are considered to have advanced - stage disease ( BCLC class C ) , independently of liver function or tumor size .", "label": "", "metadata": {}, "score": "84.43426"}
{"text": "None of the patients had complications in nontarget gastrointestinal structures .Received 22 August 2012 ; Revised 13 November 2012 ; Accepted 22 November 2012 .", "label": "", "metadata": {}, "score": "84.61102"}
{"text": "Selwyn R , Micka J , DeWerd L , Nickles R , Thomadsen B : Technical note : the calibration of 90 Y - labeled SIR - Spheres using a nondestructive spectroscopic assay .", "label": "", "metadata": {}, "score": "84.62931"}
{"text": "The one patient who did not have a documented progression event was censored at the last evaluation for progression .The secondary endpoint was overall survival ( OS ) , defined as time from SIRT until death .", "label": "", "metadata": {}, "score": "84.652115"}
{"text": "This article is published under license to BioMed Central Ltd.Affiliated with .Abstract .Background .Coincidence imaging of low - abundance yttrium-90 ( 90 Y ) internal pair production by positron emission tomography with integrated computed tomography ( PET / CT ) achieves high - resolution imaging of post - radioembolization microsphere biodistribution .", "label": "", "metadata": {}, "score": "84.912575"}
{"text": "Continuous variables were reported as medians and ranges .Comparisons among groups were calculated using non - parametric tests ( Mann - Whitney and Wilcoxon ) .", "label": "", "metadata": {}, "score": "85.311905"}
{"text": "These issues especially affect hollow viscus , such as the stomach and duodenum , as variable wall distension or compression introduces further uncertainties in manual VOI delineation .", "label": "", "metadata": {}, "score": "85.93942"}
{"text": "We analyzed the significant difference between two groups using the Mann - Whitney U test , student t test , and Wilcoxon signed - rank test .", "label": "", "metadata": {}, "score": "86.04476"}
{"text": "The terms ' predictive dosimetry ' , ' target ' , ' non - target ' , ' technical success ' , and the ' planning - therapy continuum ' were also defined in part 1 [ 1 ] .", "label": "", "metadata": {}, "score": "86.06349"}
{"text": "The circulating angiogenic factors such as vascular endothelial growth factor ( VEGF ) , interleukin 6 ( IL-6 ) , interleukin 8 ( IL-8 ) , and platelet - derived growth factor ( PDGF ) were positively correlated with tumor angiogenesis [ 25 - 28 ] .", "label": "", "metadata": {}, "score": "86.14183"}
{"text": "Results .Complete response ( CR ) was observed in 95/148 ( 64 % ) patients and a partial response ( PR ) in 39 ( 26 % ) patients .", "label": "", "metadata": {}, "score": "86.33562"}
{"text": "[ Google Scholar ] .Dvorak , H.F. Vascular permeability factor / vascular endothelial growth factor : A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy .", "label": "", "metadata": {}, "score": "86.472984"}
{"text": "Mosconi C : none .Renzulli M : none .Bolondi L : has received fees as a consultant and/or speaker from Bracco , Bayer , Roche , Bristol - Meyer - Squibb .", "label": "", "metadata": {}, "score": "87.17464"}
{"text": "HMV contributed to the design of the study , helped out with the statistical analysis and helped to draft the manuscript .KJE , BvH , ARE , MJC , IAY and HV contributed to the design of the study .", "label": "", "metadata": {}, "score": "87.3047"}
{"text": "No deaths could be attributed to the treatment .The disease control rate was 83.3 % with 2 complete responses , 13 partial responses , and 1 stable disease .", "label": "", "metadata": {}, "score": "87.5061"}
{"text": "Copyright .\u00a9 Seinstra et al . ; licensee BioMed Central Ltd. 2012 .This article is published under license to BioMed Central Ltd.Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy .", "label": "", "metadata": {}, "score": "87.574554"}
{"text": "10.1007/s12149 - 011 - 0516 - 9 View Article .J Nucl Med 2012 , 53 : 559 - 566 .10.2967/jnumed.111.097469 View Article .", "label": "", "metadata": {}, "score": "87.71825"}
{"text": "An investigation of radiosensitizers , for example , capecitabine , to be concurrently used with TARE may also be warranted as this could represent another lever to further potentiate its effects [ 37 ] .", "label": "", "metadata": {}, "score": "88.160904"}
{"text": "Acknowledgements .Electronic supplementary material .13550_2013_156_MOESM1_ESM.pdf Additional file 1 : Online resource including four additional figures ( Figure S1 , S2 , S3 , S4 ) and a table ( Table S1 ) .", "label": "", "metadata": {}, "score": "88.3645"}
{"text": "This retrospective study group included twelve men and six women , mean age 64.4 years , age range 44 - 77 years ( Table 1 ) .", "label": "", "metadata": {}, "score": "88.39251"}
{"text": "The other authors declare that they have no competing interests .Authors ' contributions .YHK , YST , GKYL , SS , AEHT , DCEN , and ASWG were involved in the study design , implementation , analysis , and manuscript preparation .", "label": "", "metadata": {}, "score": "88.607"}
{"text": "European Organization for Research and Treatment of Cancer , National Cancer Institute of the United States , National Cancer Institute of Canada .J Natl Cancer Inst .", "label": "", "metadata": {}, "score": "88.667816"}
{"text": "Sorafenib can not , however , be considered as a curative treatment since there have been no reported cases of downsizing .The objective response rate with sorafenib ( such as with other kinase inhibitors or monoclonal antibodies ) is very low , less than 3 % with the RECIST criteria .", "label": "", "metadata": {}, "score": "89.062195"}
{"text": "All authors read and approved the final manuscript .Authors ' Affiliations .Division of Internal Medicine , Department of Digestive Disease and Internal Medicine , Sant'Orsola - Malpighi Hospital , University of Bologna .", "label": "", "metadata": {}, "score": "89.4899"}
{"text": "A separate group of islet cell carcinomas in the latter study exhibited an ORR of only 34 % ( mean survival 23.2 months ) ; in the former study 10 cases with insulin / glucagon secretion were subsumed in the study population [ 12 , 13 ] .", "label": "", "metadata": {}, "score": "89.70943"}
{"text": "Ethics Statement .This study was HIPAA compliant and approved by the institutional review board of Kaohsiung Veterans General Hospital , Taiwan ( Protocol No .", "label": "", "metadata": {}, "score": "90.32405"}
{"text": "10.1016/j.ijrobp.2010.08.015 View Article .Eur J Nucl Med Mol Imaging 2011 , 38 : 1393 - 1406 .10.1007/s00259 - 011 - 1812 - 2 View Article .", "label": "", "metadata": {}, "score": "90.43248"}
{"text": "1391 - 1399 , 2012 .View at Google Scholar Abstract .Background .Hepatocellular carcinoma is a primary malignant tumor of the liver that accounts for an important health problem worldwide .", "label": "", "metadata": {}, "score": "90.60051"}
{"text": "Discussion .IL-8 , a cytokine produced by macrophage , neutrophils , fibroblasts , and epithelial cells can directly affect vascular endothelial cell proliferation , matrix metalloproteinase production , vessel endothelial permeability , and tumor metastasis [ 28 , 31 ] .", "label": "", "metadata": {}, "score": "91.008606"}
{"text": "It usually develops in the setting of chronic liver disease , mostly related to infection with hepatitis B or C , excessive alcohol intake and , today , also more as a consequence of non - alcoholic steatohepatitis ( NASH )", "label": "", "metadata": {}, "score": "91.033455"}
{"text": "90 Y radiation cross fire and beta dose spread were taken to be similar to the blurring of activity due to the partial volume effect of PET .", "label": "", "metadata": {}, "score": "91.076385"}
{"text": "[ Google Scholar ] .Dig .Liver Dis .[ Google Scholar ] [ CrossRef ] .Eur .Radiol 2009 , 19 , 1184 - 1196 .", "label": "", "metadata": {}, "score": "91.57651"}
{"text": "Department of Vascular and Interventional Radiology , Ghent University Hospital .Department of Nuclear Medicine , Ghent University Hospital .Department of Gastroenterology and Hepatology , Ghent University Hospital .", "label": "", "metadata": {}, "score": "91.81148"}
{"text": "Terzi E : none .Piscaglia F : has received fees as a consultant and/or speaker from Bracco , Bayer , GE Healthcare , Siemens .", "label": "", "metadata": {}, "score": "92.032104"}
{"text": "J. Radiol 2008 , 81 , 790 - 800 .[ Google Scholar ] .Clin .Sci .( Lond . )[ Google Scholar ] .", "label": "", "metadata": {}, "score": "92.03987"}
{"text": "90 Y absorbed dose distributions were calculated using a simplified approach based on voxel mean radioconcentrations instead of dose kernel or Monte Carlo methods .Its dosimetric rationale and evidence to support this approach are detailed in Additional file 1 .", "label": "", "metadata": {}, "score": "92.46567"}
{"text": "[PubMed ] [ DOI ] .Therasse P , Arbuck SG , Eisenhauer EA , Wanders J , Kaplan RS , Rubinstein L , Verweij J , Van Glabbeke M , van Oosterom AT , Christian MC .", "label": "", "metadata": {}, "score": "92.61502"}
{"text": "Declarations .Competing interests .The authors declare that they have no competing interests .Authors ' contributions .BAS drafted the manuscript and contributed to the design of the study .", "label": "", "metadata": {}, "score": "93.01987"}
{"text": "Guang Chen , Da - Qing Ma , Wen He , Bao - Feng Zhang , Li - Qin Zhao , Department of Radiology , Beijing Friendship Hospital , Capital Medical University , 95 YongAn Road , Xuan Wu District , Beijing 100050 , China .", "label": "", "metadata": {}, "score": "94.04395"}
{"text": "Median progression - free survival was 3.9 months ( range , 3.3 to 7.3 ) , and median overall survival was 11.2 months ( 7.1 to 31.1 ) .", "label": "", "metadata": {}, "score": "95.17049"}
{"text": "47 - 62 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at PubMed . A. Rinke , H.-H. 27 , no .", "label": "", "metadata": {}, "score": "95.25879"}
{"text": "Centre for Applied Statistics , University of Western Australia .Department of Research , Sir Charles Gairdner Hospital .Department of Radiation Oncology , National University Cancer Institute Singapore ( NCIS ) .", "label": "", "metadata": {}, "score": "95.40112"}
{"text": "Data Analysis .Categorical data were reported as number ( % ) .Measured data were reported as median ( range , minimum to maximum ) .", "label": "", "metadata": {}, "score": "95.41492"}
{"text": "A glass - based device ( TheraSphere , Ottawa , Canada ) was used .The treatment by 90 Y glass microspheres was carried out as described by Salem and Thurston [ 21 ] .", "label": "", "metadata": {}, "score": "95.57532"}
{"text": "Department of General Surgery , Singapore General Hospital .Department of Surgical Oncology , National Cancer Centre Singapore .Office of Clinical Sciences , Duke - National University of Singapore Graduate Medical School .", "label": "", "metadata": {}, "score": "97.32528"}
{"text": "Median survival was 36.0 months with 1- , 3- and 5-year survival rates of 85 % , 50 % and 26 % , respectively .", "label": "", "metadata": {}, "score": "97.4839"}
{"text": "Where prognostication is of concern , qualitative analysis alone will not suffice [ 3 ] .The scientific language of dose - response radiobiology is the radiation absorbed dose expressed in grays ( Gy ) , not the prescribed activity expressed in becquerels ( Bq ) .", "label": "", "metadata": {}, "score": "97.74265"}
{"text": "90 Y DVHs may guide future techniques in predictive dosimetry .Keywords .Yttrium-90 radioembolization Selective internal radiation therapy PET / CT Voxel dosimetry Dose - volume histogram Predictive dosimetry .", "label": "", "metadata": {}, "score": "98.0909"}
{"text": "90 Y dosimetric parameters used were as follows : half - life , 64.1 hours ; energy per decay , 0.934 MeV [ 27 ] ; absorbed dose coefficient , 49.59 Gy / GBq / kg ; and soft tissue density , 1.04 g / cm 3 .", "label": "", "metadata": {}, "score": "99.50012"}
{"text": "Relationships between alpha - fetoprotein ( AFP ) levels and total BF .Figure 4 .Relationships between alpha - fetoprotein ( AFP ) levels and total BF .", "label": "", "metadata": {}, "score": "100.04674"}
{"text": "90 Y PET voxel dosimetry was performed by a novel program written in Interactive Data Language ( IDL 6.1 ) , freely available from the corresponding author for research purposes [ 24 ] .", "label": "", "metadata": {}, "score": "100.270905"}
{"text": "The online version of this article ( doi : 10 .1186/\u200b2191 - 219X-3 - 57 ) contains supplementary material , which is available to authorized users .", "label": "", "metadata": {}, "score": "100.37285"}
{"text": "PubMed View Article .N Engl J Med 2008 , 359 : 378 - 390 .PubMed View Article .Pre - publication history .Copyright .", "label": "", "metadata": {}, "score": "102.13631"}
{"text": "334 , no .11 , pp .693 - 699 , 1996 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "103.57257"}
{"text": "40 , no . 7 , pp .686 - 692 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "105.41728"}
{"text": "90 Y is a higher energy beta emitter ( Beta max 2.2 versus 0.6 MeV ) with a broad cytoxicity range [ 27 ] .Radiation protection is a minor problem with 90 Y , a pure beta emitter , allowing day hospital protocols .", "label": "", "metadata": {}, "score": "106.125404"}
{"text": "208 , no . 3 , pp .375 - 382 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "106.31154"}
{"text": "50 , no .5 , pp .688 - 692 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "106.52814"}
{"text": "115 , no . 3 , pp .616 - 623 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "107.61586"}
{"text": "[PubMed ] [ DOI ] Received 8 June 2013 ; Accepted 4 August 2013 .Academic Editors : R. Addeo and H. M. Warenius .", "label": "", "metadata": {}, "score": "108.005585"}
{"text": "359 , no .9319 , pp .1734 - 1739 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "109.81699"}
{"text": "17 , no . 9 , pp .1425 - 1439 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "110.27617"}
{"text": "90 Y - RE .90 Y - RE will be performed using glass Yttrium-90 microspheres ( TheraSphere \u00ae , MDS Nordion , Ottawa , Ontario , Canada ) .", "label": "", "metadata": {}, "score": "111.95511"}
{"text": "228 - 247 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .194 , no .6 , pp .", "label": "", "metadata": {}, "score": "112.47039"}
{"text": "10.1371/journal.pone.0055742 View Article .Copyright .\u00a9 Kao et al . ; licensee Springer .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "119.2307"}
{"text": "6254 ) ; Fax : +886 - 735 - 075 - 81 .Received : 3 June 2013 ; in revised form : 22 July 2013 / Accepted : 15 August 2013 / Published : 27 August 2013 .", "label": "", "metadata": {}, "score": "121.67434"}
{"text": "This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "131.00706"}
{"text": "Received 2 October 2012 ; Accepted 6 November 2012 .Copyright \u00a9 2012 Murthy R. Chamarthy et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "133.80928"}
{"text": "Received 11 July 2011 ; Accepted 1 November 2011 .Copyright \u00a9 2011 Martin Vyleta and Douglas Coldwell .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "139.12512"}
{"text": "Copyright \u00a9 2013 M. Pracht et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "149.67383"}
